First Aid Kit

FIRST AID KIT

First aid kit or medical kit is a collection of supplies and equipment used to give immediate medical treatment, primarily to treat injuries and other mild or moderate medical conditions.

It is mandatory to have first aid kit in every work place like school, college, house and vehicles. It should be kept at such a place that is easily accessible. Also everyone should be aware of it. It should be labeled as “First Aid” and should have a red cross on a white background. From time to time, its items should be checked and replaced. All the required items should be available and ready for use at all times.

Components of a First Aid Kit

The minimum contents of the first aid box are as follows.

Torch 01
Thermometer – 01
Tongue Depressor (Disposable ice cream spatula)
Writing pad
Pen/pencil
Bandages of various types
Gauze pieces
Cotton
Eye pads
Scissors
Plaster
Safety pins
Tourniquet
ORS packets
Glucose packets
Methylated spirit
Tincture of iodine
Tincture of benzoin.

PERSONAL PROTECTION OF A FIRST AIDER DURING FIRST AID.

It is important to protect yourself and the casualty from infection as well as injuries. I.e. transmitting germs or infections to a casualty or contracting infection yourself from casualty.

This is because blood borne viruses such as hepatitis B, HIV may be transmitted by contact with body fluids and through giving mouth to mouth resuscitation. This increases if an infected person\’s blood makes contact with yours through a cut.

Always be watchful for your personal safety, do not put yourself personal safety, do not put yourself at risk by attempting heroic rescues in hazardous circumstances.

WAYS OF MINIMISING THE RISK OF CROSS INFECTION

Do wash your hands and wear latex free disposable gloves. If gloves are not available, ask the casualty to dress his or her own wound or enclose your hands in clean plastic bags.
Do cover cuts on your hands with water proof dressing.
Do wear a plastic apron if dealing with large quantities of body fluids and wear plastic glasses to protect your eyes.
Do dispose of all waste safely.
Do not touch any part of the dressing that will come into contact with the wound.
Do not breathe, cough or sneeze over a round while treating the casualty.

OBSERVATION TECHNIQUE USED IN FIRST AID

Every injury and illness manifests itself in distinctive ways that may help your diagnosis. These clues (guide to solution of problem) are divided into two groups: – signs and symptoms. Some will be obvious, but other valuable ones may be overlooked unless you examine the casualty, thoroughly from head to toe.

A conscious casualty should be examined, in the position found, with any obvious injury comfortably supported, an unconscious casualty\’s airway must first be opened and secured.

Use your senses: – sight, touch, hearing and smell. Be quick and alert, but be thorough and do not skimp or make assumptions. Ask the casualty to describe any sensations caused by touch as the examinations proceeds. Though you should handle the casualty gently, your touch must be firm enough to ensure that you will feel any swelling or irregularity or detect a tender spot.

What to observe for.

SYMPTOMS

These are sensations that the casualty feels or experiences and may be able to describe. You may be able to describe. You may need to ask questions to establish their presence or absence.
Ask a conscious casualty if there is any pain and exactly where it is felt. Examine that part particularly and then any other sites where pain is felt, severe pain in one place can mask a more serious, but less painful injury at another place.
Other symptoms that may help you include nausea, giddiness (loss of balance), heat, cold, weakness and impaired sensation.
All symptoms should be assessed and confirmed, whenever appropriate, by an examination for signs of injury or illness.

SIGNS.

These are details discovered by applying your senses: – sight, touch, hearing, and smell, often in the course of examination.
Common signs of injury include: – bleeding, swelling, tenderness or deformity, signs of illness that are very often evident are pale or flushed skin, sweating, a raised body temperature and a rapid pulse.
Many signs are immediately obvious, but others may be discovered only in the course of thorough physical examination.
If the casualty is unconscious, your diagnosis may have to be formed purely on the basis of the circumstances of the incident, information obtained from onlookers and signs discover.

EMERGENCY

An emergency refers to a sudden and potentially life-threatening situation that requires immediate medical attention.

PREPARING FOR EMERGENCY:

If you are prepared for unforeseen emergencies, you can ensure that care begins as soon as possible for yourself, your family and your fellow citizens.

You can be ready for most emergencies, if you do the following things now:

Keep important information about you and your family in a handy place. Information regarding address, age, medical conditions, allergies, prescription, doctor\’s name and phone number.
Keep to emergency:
Learn and stay practiced in first aid skills, such as cardiopulmonary resuscitation (CPR).
Keep the first kit readily available in your home, work place, leisure center, and cars. Any first kit must be kept in a dry place and checked and replenished (refilled) regularly, so that items are always ready for use.

GOALS OF EMERGENCY MEDICAL TREAMENT

When care is being given to a patient in an emergency situation, many crucial decisions must be made. Such decisions require sound judgment based on understanding of the condition that produced the emergency and its effect on the person.

The major goals of emergency medical treatment are:

To preserve life.
To prevent deterioration before more definitive treatment can be given
To restore the patient to useful living.

When the patient is first received into the emergency department, the goal is to determine the extent of injury (illness) and to establish priorities for the initiation of treatment. These priorities are determined by the comparative threat to the person\’s life. Injuries or conditions interfering with vital physiologic function (obstructed airway, massive bleeding) take precedence (priority). Usually, injuries of the face, neck and chest that impair respiration command the highest priorities. Every member of the emergency team must be alert to the total problem of the patient, since the body cannot be isolated into parts.

PRINCIPLES APPLIED IN EMERGENCY MANAGEMENT

The following principles are applicable to the emergency management of any patient:

Maintain a patient airway and provide adequate ventilation, employing resuscitation measures when necessary. Assess for chest injuries with subsequent airway obstruction.
Control hemorrhage and its consequences.
Evaluate and restore cardiac output.
Prevent and treat shock, maintain or restore effective circulation.
Carry out a rapid initial and ongoing physical examination, the clinical course of the injured or seriously ill patient is not static.
Assess whether or not the patient can follow commands, evaluate the size and reactivity of the pupils and motor responses.
Start electrocardiogram (ECG) monitoring, if appropriate.
Splint suspected fractures of the cervical spine in patients with head injuries.
Protect wounds with sterile dressings.
Check to see if the patient has a medical alert tag or any similar identification designating allergies.
Start a flow sheet of the patient\’s vital signs, blood pressure, neurological status, etc. to guide decision making.

ASSESSING A CASUALTY.

This involves finding out what is wrong as quick as possible, however your first priority is to make sure that your not endangering yourself by approaching the casualty unless your sure that the incident area is safe.

AIMS OF ASSESSMENT

To check the situation quickly and calmly while first protecting yourself and the casualty from any danger.
To find out and treat any life threatening injuries first.
To carry out more detailed findings of each casualty.
To seek for appropriate help, in case of an emergency or if you suspect a serious injury or illness.
To be aware of your own needs.

There are two methods of assessment namely:

Primary survey.
Secondary survey.

1. Primary survey:

This is an initial, quick and systematic assessment of casualty to establish and treat conditions that are an immediate threat to life. When dealing with each life threatening condition, work in the following order; ABC principle

Airway: Is the airway open and clear? If not, open and clear it. An obstructed airway will prevent breathing causing hypoxia and ultimately death. Breathing: Note if breathing is slow, fast, absent or gasping.
Pulse : Note the pulse for its rate, rhythm, volume and tension.
Breathing: Is the casualty breathing normally? Look, listen and feel for breaths. Blueness of tongue, lips, ear lobe and nail – Indicates lack of oxygen. If not call for emergence help and start chest compressions with rescue breaths (Cardio pulmonary resuscitation).
Circulation: Is the casualty bleeding severely? This must be treated since it can lead to life threatening condition such as shock.
Pallor : Note pallor or the degree of whiteness of tongue, conjunctiva and nails. This indicates the severity of bleeding. Therefore, control the bleeding and treat the casualty to minimize the risk of shock. Bleeding from any part of body and swelling. N.B: If the threatening conditions are successfully managed or there are none, you carry on assessment and perform a secondary survey.

2. Secondary survey: This is a detailed examination of the a casualty to look for other injuries or conditions after a primary survey has been done it involves;

Head to toe

(i) Head:

– Observe skin color, wound, confusion and facial symmetry.

– Check pupils

– Assess level of consciousness

– Palpate for depression of the skull.

– Check ears and nose for fluids or blood.

– Check the mouth for bleeding, dentures and any foreign body.

(ii) The neck: Observe and palpate for areas of tenderness and deformity.

(iii) Chest:

Palpate clavicles and shoulders.
Observe for wounds and whether the chest expands normally upon respiration.
Press gently on sternum and ribs to check integrity.

(iv) Arms:

Palpate entire length for pain, wounds, deformity and sensation.

Ask about pain, tingling, numbness and movement.

(v) Abdomen:

Observe for distension or wounds.
Pal pet for rigidity or tenderness.

(vi) Pelvis:

– Palpate the iliac crest and the pubis for pain.

– Observe for incontinence of the bladder and the bowel.

(vii) Spine: Palpate for tenderness, wounds and deformity.

(viii) Legs: Palpate entire length for pain; deformity and sensation.

(b) HISTORY TAKING

– Ask what happened

– Ask about medical history to find out if there is ongoing and previous condition

– Ask about medication the casualty is taking currently

– Find out if the person has any allergy.

– Check when the person last had something to eat or drink

NOTE: Use ‘’AMPLE’’ as a reminder when assessing a casualty to ensure that you have covered all aspects of examination.

A – Allergy

M – Medication

P – Previous medical history

L – Last meal

E – Event history (what happened).

(c) SYMPTOMS: These are sensations that the casualty feels and describes to you. For example if the casualty complain of pain.
(d) SIGN: These are features that can detect by observing and feeling the casualty such as swelling, bleeding, discoloration, deformity and smells. Use all your senses to look, listen, feel and smell.

POINTS TO CONSIDER WHEN DEALING WITH CASUALTY

Make eye contact but look away now and then so as not to stare.
Use a calm, confident voice that is loud enough to be heard but do not shout.
Do not speak to quickly.
Keep instructions simple by using short sentences and simple wards.
Use affirming nods and ‘mmms’ to show that you are listening when the casualty is speaking.
Check that the casualty understands what you mean.
Do not interrupt the casualty but always acknowledge what you are told. For example summarizing what the casualty has told you to show that you understand.
Be aware of risks.
Build and maintain the casualty trust.
Call appropriate help.

POSITIONING OF A CASUALTY:

A casualty is nursed in different positions in different situations. The commonly used positions are;

Recovery position
Prone position
Fowler’s position/ sit up position
Dorsal recumbent position.
Positioning in shock.

RECOVERY POSITION:

This is used in unconscious patients/ casualties if breathing and has heart beat should be nursed in recovery position.

ADVANTAGES:

It maintains open air way.
The tongue cannot fall to the back of the throat.
Head and neck will remain in the extended position so that the air passage is widened and that any vomiting or other fluid in the casualty’s mouth will drain freely.

$\"recovery$

The recovery position is as follows:

Place the body in the prone position.
Turn the head down to the one side. No pillows should be used under the head.
Pull up the leg and the arm on the side to which the head is facing.
Pull up the chin.
Stretch other arm out as shown.
His clothes should be loosened at the neck and waist and any artificial tooth should be removed.

NOTE: Recovery position cannot be used in:

When there are fractures to the upper or lower body.
When the casualty is lying in a confined space or if it is not possible to bend the limbs.

PRONE POSITION

A patient is placed on his abdominal with head turned to one side. A pillow is placed under the head and hand’s kept on sides. This position is used for patients with burns of the back.

$\"prone$

FOWLER’S POSITION/ SIT UP POSITION

When a patient is having difficulty in breathing, this position is used. The patient is kept in a sitting position with the help of 3 or 4 pillows.

$\"FOWLER’S$

4. DORSAL RECUMBENT POSITION

The patient is kept on his back. A pillow is placed under the head. It is used for examination of the patient. This position without pillow is used in case of fracture of the spine and also to give CPR (cardio pulmonary resuscitation)

$\"DORSAL$

5. POSITIONING IN SHOCK.

Lay the casualty on the back turn head to one side. Raise the legs with two pillows to improve blood supply to the heart. If the victim has fracture on the lower limbs, it should not be elevated unless they are well splinted.

$\"POSITIONING$

RESUSCITATION (BASIC LIFE SUPPORT)

Basic life support is an emergency life saving procedure that consists of recognizing and correcting failure of the respiratory and the cardio vascular system.

Basic life support comprises of ABC steps which concern the Airway, Breathing, and Circulation respectively.

For any one’s life to continue, the body needs adequate supply of oxygen to enter the lungs and transferred to all cells of the body through the blood stream. The most critical organ that should not fall short of Oxygen is the brain since it’s the master controller of all body functions.

Brain damage is possible if the brain is deprived of Oxygen for 4-6 minutes.

NOTE: Once you have started basic life support, do not interrupt it for more than 5 seconds for any reason accept it’s necessary to move the patient. Even in that interruption should not exceeds 7 seconds each.

THE RESUSCITATION SEQUENCE

1. CHECKING RESPONSE:

On discovering a collapse casualty, you should first establish whether he/she is conscious by asking simple questions like, what has happened or command the patient to do something e.g. ‘’open your eye’’.
Speak loudly and clearly close to the casualty’s ears. If the casualty does not respond, try to shake his shoulders gently as you speak to him/her (fully unconscious casualty will make no response at all).
The casualty may respond to pain, so you can gently pitch his/her skin.
A casualty who is partially conscious makes unnecessary movements on pitching.

NOTE: Quick assessment can be done using the ‘’AVPU’’ code.

A – Alert

V – Response to voice

P – Response to pain

U – Unresponsive.

CHECK POINTS

Eyes
Speech
Movement

HOW TO OPEN THE AIRWAY

Place the person in are recumbent position (face up) on a hard surface.
Place one hand on his fore head and gently tilt his head back. As you do this, the mouth will fall open slightly.
Place the finger tips of your hand on the point of the casualty’s chin and lift the chin up.
Check the casualty’s breathing.

HOW TO CHECK FOR BREATHING:

Keeping the air way open look, listen and feel for normal breath.

Look for chest movements.
Listen for sounds of breathing.
Feel for breaths on your own cheek and see movement.
Along her chest and abdomen.

Do this for not more than 10 seconds before deciding whether the casualty is breathing normally.

NOTE: If there is any doubt, act as if breathing is not normal.

IF THE CASUALTY IS BREATHING

Check the casualty for any life threatening injuries e.g. severe bleeding and manage it as necessary
Place the casualty in a recovery position.
Call for emergency help e.g. call for the nearest ambulance services.
Monitor and record vital signs for example, level of response, breathing as you wait for help to arrive.

IF THE CASUALTY IS NOT BREATHING

Shout or ask for help (dial for an ambulance).
Begin cardio- pulmonary resuscitation with chest compressions.

HOW TO GIVE CARDIO PULMONARY RESUSCITATION

Kneel the casualty’s level with his chest.
Place the heel of one hand on the center of the casualty’s chest.
Place the heel of your other hand on top of the first hand and interlock your fingers making sure the fingers are kept off the ribs

Leaning over the casualty with your arms straight, press down vertically on the breast bone. (Sternum) and depress the chest 5 – 6cm (2 – 2 1/2inch).
Allow the chest to come back up fully before giving the next compression.

Compress the chest 30 times at a rate of 100 – 120 compressions per minute. The time taken for compression and release should be about the same.
Move the casualty’s head and make sure that the airway is still opened.

Put one hand on his fore head and two fingers of the other hand under tip of his chain.
Move the hand that was on the fore head down to pitch the soft part of the nose with the finger and the thumb.
Allow the casualty’s mouth to fall open.

Take a breath and place your lips around the casualty’s mouth making sure that you have made a good seal. Blow into the casualty’s mouth until the chest rises. A complete rescue breath should take one second. Adjust the head position if the chest doesn’t rise.
Maintaining the head tilt and chin lift, take your mouth off the casualty’s mouth and look to see the chest fall. If the chest rises visibly as 61,000 and falls fully when you lift your mouth a way, you have given a rescue breath. Give a second rescue breath.

8. Continue the cycle of 30 chest compressions followed by two rescue breaths. This is done until emergency help arrives or another first aider takes over or until the casualty shows signs of regaining consciousness, such as coughing, opening eyes, speaking or moving purposely e.tc. It can also be until you are too exhausted to continue.

$\"HOW$

First Aid Kit Read More »

First Aid

First aid: refers to initial or immediate assistance given to someone who has sustained an injury or got a sudden illness before the arrival of an ambulance, a doctor or any other qualified person.

Or: Is immediate care given to the injured or suddenly ill person. First aid does not take place in presence of proper medical treatment.

It consists only of giving temporary assistance until competent medical care, if needed, is obtained, or until the chance of recovery without medical care is ensured. Most injuries and illnesses require only first aid care.

First aid includes assessing the victim for life-threatening conditions, performing appropriate intervention to sustain life and mental conditions until he/she can enter the emergency or casualty unit in the hospital.

F-Fast arrival

I-Intelligent

R-Recording and reporting

S-Safety precautions

T-Timely action

A-Alertness

I-Initiation and implementation

D-Decision making

First aider: Is a person who is capable of providing first aid to a casualty.
A casualty: This is any person who has sustained an injury or a sudden illness.
By- standers or on- lookers: These are people around the accident or the emergency scene.

AIMS OF FIRST AID

Save life
Promote life
Prevent worsening of the casualty’s condition
Relive pain and anxiety
Make the casualty as comfortable as possible
Ensure that proper and immediate medical care is available.
Transport the casualty to the nearest hospital at the earliest.

SCOPE OF FIRST AID

- Diagnosis: Determine the nature of the case requiring attention so far, as is necessary for intelligent and efficient treatment or diagnosis. I.e. Diagnosis: – Taking proper history, checking signs (bleeding pile) and symptoms (pain).

Treatment: To decide the character and extent of the treatment to be given and to apply the treatment, which is most suited to the circumstances until medical aid is available. I.e. Treatment: Remove the cause. Make the casualty comfortable and continue assistance till doctors arrives.

Apply treatment which is most suited to the circumstances until medical aid is available.

Disposal: Arrange for disposal of the casualty by shifting him either to his home or other suitable shelter or to hospital. I.e. Disposal: To nearest shelter, by the quickest means and to send a word to relatives.

PRIORITIES OF TREATMENT IN CASE OF AN ACCIDENT

The first aider should;

Observe carefully
Think carefully
Act quickly

OTHER FIRST AID PRIORITIES:

Assess the situation quickly and calmly.
Protect yourself and the casualty from danger. Never put yourself at risk.
Prevent cross infection between yourself and casualty as possible.
Comfort and reassure casualties at all times.
Assess the casualty by identifying the injuries or nature of illness affecting him or her.
Give early treatment and treat the casualties with the most serious or life threatening conditions first.
Arrange for appropriate help. I.e. call for emergence help if you suspect a serious injury or illness or arrange for transportation of the casualty hospital or his home.

QUALITIES OF A GOOD FIRST AIDER

Observant: First aider should use all his senses and closely observe the cause of accident and its effect on the casualty.
Tactful: First aider should be tactful in dealing with casualty, crowd, doctor and relatives. He should be sensitive to the needs of the casualty and take prompt action.
Self–control: On seeing the accident, the first aider should have self-control and not get panic or excited.
Resourceful: First aider should be resourceful and make use of anything available at site of rescue to save life.
Knowledgeable: One should have good knowledge of accidents, emergencies, rescue measure, disease conditions, disasters, etc.
Skillful: One should have skill in taking vital signs, control of bleeding, cardio pulmonary resuscitation, bandaging, caring for sick, etc.
Empathy: A good first aider must have empathy and be understanding. (This is known as a good Samaritan principle).
He/she must be able to act quickly.
He must have common sense.
Discriminating: First aider may decide which of the several injuries should be given attention.
Explicit: Giving clear instructions to the patient and advice to the assistants.
A good first aider must be updated with knowledge and skills.
He/she must have the ability to make decisions quickly.

OBJECTIVES OF FIRST AID

The objectives of first aid are:

To preserve life.
To prevent further injury and deterioration of the condition.
To prevent complications related to injury or illness conditions.
To make the victim as comfortable as possible to conserve the strength.
To put the injured person under professional medical care at the earliest.

BASIC OBJECTIVES OF PSYCHOLOGICAL FIRST AID

To establish a human connection in anon intrusive compassionate manner.
To enhance immediate and ongoing safety, and provide physical and emotional comfort. Calm and orient emotionally overwhelmed or distraught survivors.
To help survivors to articulate immediate needs and concerns, and gather additional information as appropriate.
To offer practical assistance and information to help survivors address their immediate needs and concerns.
To connect survivors as soon as possible to social support networks, including family, neighbors and community helping resources.
To support adaptive coping, acknowledge coping efforts and strengths, and empower survivors, encourage adults, children and families to take an active role in their recovery.
To provide information that may help survivors to cope effectively with the psychological impact of disasters.
Facilitate continuity in disaster response efforts by clarifying how long the psychological first aid provider will be available and (when appropriate) linking the survivor to another member of a disaster response team or to indigenous recovery systems, mental health services, public sector services and organizations.

GOLDEN RULES OF FIRST AID

Do first things quickly and without fuss or panic.
Give artificial respiration, if breathing has stopped every second.
Stop any bleeding.
Guard against or treat for shock by moving the casualty as little as possible and handling him gently.
Do not attempt too much do the minimum that is essential to save life and prevent the condition from worsening.
Reassure the casualty and those around and so help to lessen anxiety.
Do not allow people to crowd round as fresh air is essential.
Do not remove clothes unnecessarily.
Arrange for the removal of the casualty to the care of a doctor or hospital as soon as possible.

PRINCIPLES OF FIRST AID (ACTION AT AN EMERGENCY)

Remove the casualty to a place of safety
Loosen clothing around the neck and waist, to help breathing
Reassure the patient
Look for the following:

Is there any failure of breathing? If yes, start artificial respiration.
Is there any failure of circulation? If yes, start external cardiac massage.
Is there severe bleeding? If yes, stop bleeding by pressing firm on pressure areas with a clean pad for few minutes.
Are there any signs and symptoms of shock? If yes, treat shock

5. Relieve pain
6. Avoid handling the casualty unnecessarily.
7. Arrange for safe removal of the casualty to the hospital.

GENERAL RULES OF FIRST AID

Reach accident spot quickly. This will help to save life of the casualty.
Shout for help. Organize labour or onlookers or bystanders to help in any possible way. Make sure there are enough people to help you.
Be calm, methodical and quick. By doing so, you can minimize the pain and the effect of the injuries, which may save life. Handling casualty clumsily will make the final recovery difficult.
Remove the casualty from danger or danger from casualty.
Look for the following:

Is there failure of breathing?
Is there severe bleeding?
Is the shock high or severe? Is there any signs/ symptoms of shock?
Attend to these and then treat easily observable injuries.
Start artificial respiration, if the casualty is not breathing, it must begin at once, as every second gained is helpful.
Stop bleeding by pressing on the pressure point, press firmly on the bleeding area for at least a few minutes (minimum 3 minutes) by watch – take help if available.
Treat shock
Avoid handling casualty unnecessarily.

Note: Never give anything by mouth to the patient who is unconscious.

Use the first aid articles if available (All trains, railway stations, Lorries and buses keep first aid box). Make use of material so obtained. In case, first aid box is not available, improvise and make use of available resources.
Assess the situation sensibly in regard to medical aid treatment which may be needed.
Make a written note on the general condition and your findings about the casualty.
Inspect the area: Take the casualty away from live wire, fallen walls, beams, fire, broken gas chamber, moving machinery, etc. to safer place.
Clear the crowd with polite words. Do not allow people to crowd around the casualty as the casualty needs fresh air. If a doctor is present, he will guide you. Any other first aider should be asked to help, otherwise take the assistance of by standers by giving them correct instructions.
Note the weather: If it is not raining, too hot or cold, treat in open, otherwise move the casualty into an airy room. If no suitable house or shelter is available nearby, it’s best to protect the casualty with an umbrella or a sheet of cloth or even a newspaper.
Reassure the casualty by soft words and encourage talking. This will help the casualty to take things lightly and lie quietly. This will help in recovery.
Arrange for dispatch of the casualty to the care of a doctor or to a nearby hospital. At the same time inform relatives as to where the casualty is being taken to.
Do not attempt too much. You are only a first aider, give minimum assistance so that condition does not become worse and life can be saved.

DO’S AND DON’T’S

Do not forget that you are not a doctor hence, do not attempt to overdo things.
Do not handle the victim unnecessarily as that condition may worsen.
Do not expose the casualty unnecessarily
Do not open any wounds / dressing, if bandaged previously by anybody.
Do not move any fracture case without putting proper splints.
Do not tie tourniquet at bleeding site and forget about it.
Attend to casualty as per priority.
Attend to children and women first.
Ensure self – safety and security before jumping into heroic attempts to save casualty
Follow precautions in handling communicable / infectious cases.
Never declare any casualty dead, it is that doctor’s job.

THE MANAGEMENT OF THE CASE

The first aider must always:

Respond quickly to calls for assistance, the saving of a life may depend on promptness of action.
Adopt a calm and methodical approach to the casualty, quick and confident examination and treatment will relieve pain and distress, lessen the effect of injury and may save life. Time spent on long and elaborate examination of a casualty may be time lost in his ultimate recovery.
Treat obvious injuries and conditions endangering life such as failure of breathing, severe shock, before making a complete diagnosis.
Take first aid material. If this is immediately available. If standard equipment is not available the first aider must depend on material to hand which will have to be provided as required.
Study the surroundings carefully. These may influence the action to be taken and therefore require careful consideration for example:
Danger: From falling building, moving machinery, electric current, fire, poisonous gases and similar hazards.
Weather: If the accident occurs out of doors, the casualty may be treated in the open if the weather is fine, if the weather is bad, he must be removed to shelter as soon as is reasonably possible.
Shelter: Note houses and buildings near at hand, whether occupied or unoccupied and whether likely to be particularly useful, such as a chemist’s shop, otherwise, temporary shelter may be provided by means of umbrellas, rugs and the like.
Assistance: Crowds must be tactfully controlled. If a doctor is present, work under his direction. If not, ask if anyone with knowledge of first aid is present. If neither is available make use of bystanders to the best advantage.
Reassure the casualty by speaking encouragingly to him. Warm him to be still and tell him that he is in trained hands.

STEP BY STEP ACTION TO BE TAKEN BY THE FIRST AIDER

Examination and Diagnosis: This is taking account of the casualty‘s history and that of incident, symptoms, signs and level of responsiveness.
History: This is the full story of how the incident occurred or the illness began, and should be taken directly from the casualty and a responsible bystander wherever possible.
Never hurry the casualty and remember to pass on all information you have obtained when skilled help arrives.
Symptoms: These are sensations that the casualty feels and describes to you the most useful of these is pain. If the casualty is unconscious or unreliable because dazed (confused) or in shock, their diagnosis cannot be based on symptoms but has to be based on information obtained from bystanders and signs.
Sign: These are details ascertained by you using your senses – sight, touch, hearing and smell. These may be signs of injury such as: bleeding, swelling, deformity, or signs of illness such as raised temperature and rapid or regular pulse.

Cardiopulmonary resuscitation (every second).
Control bleeding.
Treat shock and special care of unconscious cases.
Fracture immobilization
Burn cover, with clean washed or dressing and treat shock.
Eye, nose and ear injuries.
Multiple superficial injuries.
Transportation

RESPONSIBILITIES OF A FIRST AIDER IN THE MANAGEMENT OF CASUALTIES:

Gain access to the patient in easiest and safest way.
Observe the accidents scene and assess the situation.
If necessary, direct others to direct traffic keep bystanders at a safe distance and make essential telephone calls. Turn off all engines that may be still running.
To find out whether is unconscious, conscious alive dead.
Identify the disease or condition from which the casualty is suffering.
Give immediate, appropriate and treatment considering priority of the first aid measures. Such as first priority will be of restoration of breathing and circulation, while second will be stopping the bleeding.
Should bear in mind that a casualty may have more than one injury and that some casualties will require more urgent attention than others.
Arranging without delay for shifting of the casualty to a doctor, hospital or home according to the condition in such a manner that injury is not complicated or the victim is not subjected to unnecessary discomfort.
Keeping the record of the patient and of the patient and of incidence, addresses and witness.
Once a first aider has voluntarily started care, he should not leave the scene, or stop the care until a qualified and responsible person relieves him.
To report your observations to those taking over care of the casualty and to give further assistance if required.
To prevent cross infection between yourself and casualty as much as possible.

LIMITATIONS OF THE FIRST AIDER

The first aider should be observant with the rules or objectives of first aid and act quickly and vigilantly.
He should inspire confidence in the patient and others closely related to the patient.
To save lives, there are three conditions that call for first aid: – stoppage of breathing, severe bleeding and shock.
If breathing movements are not proper, the lips, tongue and finger nails become blue, in such a situation, artificial respiration should be started immediately.
If there is heavy bleeding: It may be from wounds through one or more large vessels. In this condition, pressure should be applied directly over the wound. For this, a clean handkerchief or a pad may be kept on the wound and pressed firmly with one or both hands, then apply affirm bandage.
The important factor to be attended immediately is shock. Shock accompanies severe injury or emotional disturbance. Cold and clammy skin, beads of perspiration on the fore head and palms. Pale face, nausea and vomiting are the common symptoms of shock.

SKILLS REQUIRED FOR THE FIRST AIDER:

Control the scene of accident.
Gain access to the patient.
Evaluate the scene in terms of safety and possible cause of accident.
Gather information from patient and bystanders.
Determine vital signs (pulse, breathing, skin, temperature)
Determine diagnostic signs and relate those to possible injuries or sudden illnesses that require emergency care.
Perform the necessary ABC’S of emergency care:

Open air way.
Breathing (breathlessness- provide artificial ventilation).
Circulation (pulseless- provide one and two rescuer cardiopulmonary resuscitation).
Bleeding control (haemorrhage controlled by direct pressure and elevation, pressure points and tourniquets).

Diagnosis and care for shock.
Diagnosis and care for open and closed fractures, sprains (tearing of ligaments), strains (muscle injured by overstretching) and dislocations, including cold treatment and basic splinting techniques.
Diagnosis and care for soft tissue and internal injuries including basic dressing and bandaging techniques.
Detect and care for poisoning including alcohol and drug abuse.
Diagnosis and care for heart attack, stroke, diabetes, coma, insulin shock, and epileptic or other seizures.
Diagnosis and care for facial injuries, head injuries, neck and spinal injuries and chest injuries including fracture ribs and penetrating chest wounds
Diagnosis and care for burns and smoke inhalation.
Diagnosis and care for exposure to heat and cold, which includes heat exhaustion, heat cramps, heat stroke, hypothermia and frostbite.
Assist in child birth and care of the new born.
Psychological and proper emergency care to victims of crisis and disasters.
Perform proper transformation techniques.

First Aid Read More »

Question Approach

Guide to the Question Approach for Midwifery Exams

It is important for midwives preparing for the exam to be able to answer questions effectively.

This approach allows you to tackle questions in a systematic manner, ensuring that you cover all important points and provide concise and accurate answers. By following this structured approach, you will be able to effectively demonstrate your knowledge, critical thinking and analytical skills, leading to higher scores and overall success on your midwifery exams.

Whether you are facing questions that require you to EXPLAIN, OUTLINE, DESCRIBE, MENTION, IDENTIFY, STATE, LIST, WHAT and GIVE, this article is all you need!

Explaining Questions: Breaking Down Complex Concepts

When questions require explanations, it is essential to break down complex concepts into understandable parts. Start by introducing the topic you\’re discussing and providing a concise definition if necessary. Then, proceed to explain on the key components or factors related to the topic. Use clear and simple language to ensure your explanation is easily understandable.

Example Question: Explain how you would admit a mother who has reported in active phase of first stage?

In response to this question, you can follow the question approach by giving the key points step by step:

Reception: the mother and the relatives are welcomed; mother is taken to the admission room while the relatives are offered seats. Rapport between the mother, attendants and the midwives is created.
History taking: if the mother has been attending ANC, her ANC record is obtained; to get the history and any risk factors like multiple pregnancies. If she has not been attending ANC, a full antenatal history is taken, which involves the mother‘s name, address, tribe, religion, husband‘s name and address, her gravida and parity, obstetrical, surgical, social, and medical history, the time and date of admission are entered in the admission forms of the mother.

Then, history of labour under the following headings is recorded:

Show: the mother is asked if she has seen any blood and mucus, her undergarments examined for any stain, vulva examined for the drainage of show which may appear a few hours before or after beginning of labour.
Uterine contractions: mother is asked when the regular pains began, how often and if she has backache. Her statement about the length, severity, or expulsive character of the contraction should be confirmed by observation and evaluation then
Membranes: She is asked whether her water (amniotic fluid) have ruptured or not; if she has noticed a gush or tickling of water → the amount and time are recorded. If in doubt of whether its liquor or urine, litmus paper is dipped into the draining fluid obtained from the vulva to confirm alkalinity or
Vaginal discharge or bleeding: the mother is also asked if she had any vaginal bleeding/ discharge which should be excluded

General examination of the mother: her general appearance is noted, that is healthy or ill, colour, any deformities like lame, presence of oedema, infections, varicose veins or enlarged neck veins. Breast examination is carried out to identify their sustainability for breast feeding
Observations; Vital signs are monitored like temperature, pulse, respiration and blood pressure to rule out eclampsia in She is also asked for bowel action, sleep and rest
Abdominal Examination: first, the bladder should be empty and this is carried out with the mother lying on the couch on supine position with a pillow under her head and This examination is carried out as follows:
- On inspection: the shape of the abdomen is noted whether round or oval, the size should be correspond with the weeks of gestation, the foetal movements, skin changes like stria gravidarum and linea nigra and any scar are
- On palpation: this can be superficial, fundal, lateral, pelvic, height of the fundus and hypochondriac. They are carried out to note the lie whether its longitudinal, transverse, or oblique; the position of the fetus which can be ROA, LOA, ROP, LOP; and engagement plus enlargement of the spleen and the liver.

On auscultation: the fetal heart is listened, if its heard and regular

Vulva shave, toilet and examination: the shave is done on women whose cultures allow keeping the vulval area with pubic hair. Any abnormal discharges, oedema, or paleness are noted if present
Vaginal examination: this is done to mothers who have no history of APH with the current pregnancy under strict asepsis. It‘s done to confirm the onset of labour, the presentation, position, engagement, station of the presenting part, to confirm whether membranes ruptured or intact, exclude cord prolapsed, assess the pelvis if adequate or inadequate and also progress of labour and it‘s the one that determines the admission of a mother on the partograph
Investigations: routine samples are obtained for example:
- Blood: for routine counseling and testing (RCT), rapid polymerase reaction (RPR), HBsAg, haemoglobin estimation, Grouping and cross matching → rational to confirm presence of any disease so as to prevent mother to child transmission (MTCT) and for blood transfusion (BT) in case of anaemia
- Urine: for analysis to test for albumin, sugar, acetone that might complicate labour

Personal hygiene: a shower is both hygienic and pleasant. If the mother‘s membrane have ruptured or in advanced first stage of labour, she is sponged down on a couch and given a clean

Admission: the mother is then admitted on a partograph, all the necessary information recorded and the continuous observation of the mother takes place accordingly

Outlining Questions: Structuring Information

When faced with outlining questions, it is important to structure your response in a logical and organized manner. Begin by providing an the main points or components related to the topic. Use subheadings to break down the information further, making it easier for the examiner to follow your answer.

Example Question: Outline the changes that take place in the uterus during the first stage of labour?

Before answering the proposed question above, it‘s vital to first define the following terms:

Labour: is the process by which the foetus, placenta and the membranes are expelled out of the birth canal after 28^th weeks of gestation
First stage of labour: is the period of dilatation of the cervix lasting from the onset of true labor till full dilatation.

During the first stage of labour the following occurs:

Effacement or take up of the cervix: this is made possible by the work of muscle fibres surrounding the internal OS which are drawn upward by the retracted upper segment.
Pacemaker / Fundal dominance: each contraction begins from the pace maker situated at the cornua of the uterus. From the fundal region it spreads downwards being stronger and persisting longer in the upper region on reaching the lower region, the wave of contraction weakens and allows the cervix to dilate.
Dilatation of the cervix: this is the opening of the external OS to allow the passage of the fetal head; it occurs as a result of uterine action and the pressure from fore bag of waters and the well fitting presenting part
Contraction and Retraction: is the special ability of the uterine muscle where the contraction does not pass off completely and the muscle fibres, retaining some of the contractions, do not become completely relaxed, instead they become gradually shorter and thicker.
Polarity: is the term used to define the coordination between two poles of uterus throughout labour.
Development of upper and lower segment: the upper uterine segment is the thicker muscular contractile part. The lower part segment is the firm distensible are of 7.5cm – 10cm in length developed from isthmus to the uterus.
Development of retraction ring: is the ridge formed between the upper and the lower uterine segment. It‘s present in labour and normal as long as it‘s not marked enough to be visible above the symphysis pubis. NB: It is called bandl‘s ring in obstructed labour
Show: is the blood stained mucoid discharge seen a few hours within or a few hours after when labour has started.
General fluid pressure: while the membranes remain intact, the pressure of the uterine contraction is exerted on the fluid as the fluid is not compressible the pressure is equalized throughout the uterus.
Rupture of membranes: rupture of membranes may be early or later during the second stage of labour due to the malpresentation and pressure from the presenting part.
Fetal axis pressure: this is when the force of contractions from the uterus is transmitted via the long axis of the canal; this becomes more significant after the rupture of membranes and during second stage.

Describing Questions: Providing Detailed Information

Describing questions require you to provide detailed information about a specific topic or concept. When answering these questions, you have to offer a comprehensive and thorough response, including relevant facts, characteristics, and examples. Use clear language and provide specific details to enhance the depth of your description.

Example Question: Describe the vagina.

Definition: Vagina is a muscular fibrous canal which forms the part of the internal female reproductive organs.

Situation: It is a canal which extends from the vestibule below to the cervix above running in an upward and backward direction between the planes of the pelvic brim.

Shape: It is a potential tube which runs upwards and backwards with its walls in close contact but can be separated during coitus, menstruation, vaginal examination and child birth.

Size: The anterior wall measures 7.5cm. The posterior wall is longer and it measures 10cm.This is because the uterus enters the vagina at an angle of 90 degrees and bends forwards towards the anterior wall hence it encroaches on it

Structure

Gross structure

Superiorly; the upper end of the vagina is known as the vault, where the cervix protrudes into the vault it forms circular recess known as fournices.

The vagina is made up of four fournices that is to say;

The anterior fornix which is smaller and fairly deep The 2 lateral fournices which are shallow
The posterior fornix which is the longest and deepest
The lower end of the vagina is narrow and inferiorly we find the vulva, hymen enclosing the vaginal opening only present in virgins. If hymen is ruptured it leaves tags of membranes referred to as carunculae mytiformes. Vaginal orifice is also called introitus.

Microscopic structure

It is made up of four layers;

Squamous epithelium arranged in folds known as rugae and makes the inner most layer of the vagina, the rugae increase the surface area and offer the vagina ability to stretch when need be for example during coitus and child bearing.
Vascular connective tissue layer which is rich in blood vessels, nerves and lymphatics and is found just beneath the epithelium.
Muscular layer. This is thin but a strong layer which is divided into two; the weak inner circular and strong outer longitudinal fibres.
The pelvic fascial which is made up of loose connective It forms the outer protective coat and is continuous with the pelvic fascia.

Blood supply (arterial): The vagina is supplied by the branches of internal iliac artery which include vaginal artery and uterine artery.

Venous drainage: By the corresponding veins i.e branches of internal iliac veins which include vaginal veins and uterine veins.

Lymphatic drainage: Into the inguinal, the iliac and the sacro glands

Nerve supply: By the sympathetic and parasympathetic nerves which are branches from the lee Franken lanser plexus

Contents of the vagina

It doesn‘t contain any glands but its kept moist by cervical mucus and a transudation from the underlying blood vessels through the epithelium.
Its media is acidic (PH 3.8 to 4.5) and this is made possible by presence of lactic acid after action of doderleins bacilli on glycogen.

Relationships of the vagina

Anteriorly: Below, the base of the bladder rests on the upper ½ of the vagina and the urethra is embedded in the lower ½.

Posteriorly: Pouch of Douglas above, the rectum medial and perineal body below.

Laterally: Pubococcygeous muscles below and pubic fascial containing the uterus above.

Inferiorly: The structure of the vulva.

Superiorly: The cervix and the fournices.

Functions of the vagina

Exit from menstrual flow.
Entrance for spermatozoa.
Exit for products of conception.
Supports the uterus.
Prevents ascending infection due to acidic PH.
For assessing the pelvis.
Drug administration.

Mentioning, Identifying, and Stating Questions: Being Clear and Concise

When faced with questions that require you to mention, identify, or state specific information, it is essential to be clear, concise, and accurate in your response. Avoid unnecessary elaboration and focus on providing the requested information directly.

Example Question: State the major components of a comprehensive birth plan?

To answer this question effectively, you can provide a concise statement listing the major components of a birth plan:

A comprehensive birth plan typically includes the following components:

Preferred birth environment (hospital, birthing center, home birth)
Pain management preferences (medication, natural methods, water birth)
Support people and their roles during labor and delivery(husband, mother)
Positioning preferences for labor and birth(lithotomy)
Preferences for fetal monitoring during labor
Neonatal interventions and care preferences immediately after birth
Feeding preferences (breastfeeding, formula feeding)
Cultural or religious considerations
Preferences for postpartum care and rooming-in with the baby
Contingency plans for unexpected situations or interventions

By providing a clear and concise statement of the major components, you address the question directly and effectively.

Listing and Giving Questions: Providing Comprehensive Information

When asked to list or give information, it is important to provide a response that covers all the relevant points. Ensure that you include all necessary information without leaving out any key details.

Example Question: List and give examples of common obstetric emergencies that midwives may encounter?

In response to this question, here is a comprehensive list of common obstetric emergencies along with examples:

Postpartum Hemorrhage (PPH): This is excessive bleeding following childbirth. Examples include uterine atony (lack of uterine contractions), retained placenta, or trauma to the birth canal.
Shoulder Dystocia: It occurs when the baby\’s shoulders become stuck behind the mother\’s pubic bone during delivery. This can lead to complications such as brachial plexus injury or fetal hypoxia.
Umbilical Cord Prolapse: The umbilical cord slips through the cervix ahead of the baby, potentially cutting off the baby\’s oxygen supply. This requires immediate action to relieve pressure on the cord.
Amniotic Fluid Embolism: This is a rare but life-threatening condition where amniotic fluid enters the mother\’s bloodstream, triggering an allergic reaction. It can result in cardiac arrest, respiratory failure, or disseminated intravascular coagulation (DIC).
Pre-eclampsia/Eclampsia: Pre-eclampsia is characterized by high blood pressure and organ damage during pregnancy, while eclampsia is the development of seizures in a woman with pre-eclampsia.
Placental Abruption: This occurs when the placenta separates from the uterine wall before delivery. It can cause severe bleeding and compromise fetal oxygen supply, necessitating emergency delivery.
Fetal Distress: This refers to a compromised fetal condition during labor, usually due to inadequate oxygen supply. It may require interventions such as changing maternal positions, administering oxygen, or performing an emergency cesarean section.
Cord Compression: The umbilical cord becomes compressed during labor, restricting blood flow to the baby. This can occur due to cord entanglement, excessive cord length, or abnormal positioning.
Maternal Infections: Infections such as chorioamnionitis (infection of the placental membranes), sepsis, or genital tract infections can pose risks to both the mother and the baby.
Maternal Hypertensive Disorders: These include gestational hypertension, chronic hypertension, and HELLP syndrome.

Write Short Notes: Concise and Informative Summaries

When encountering \”Write Short Notes\” questions, the aim is to provide concise yet informative summaries of the given topic. These questions require you to summarize the key points and present them in a clear and organized manner. Avoid excessive details and focus on providing a brief but comprehensive overview.

Example Question: Write short notes on the following

(a) Causes of pain in labour.

(b) Factors that affect pain perception during labour.

(a)CAUSES OF PAIN

There are two major causes of pain

Hormonal factors
Mechanical factors

Hormonal factors These include;

Oxytocin stimulation. This increases the strength, intensity, duration and frequency of the contractions leading to pain.

Progesterone withdrawal. The reduced levels of progesterone lead to an increase in estrogen levels which stimulates the muscles of the deciduae muscles of the uterus to produce prostaglandin which stimulates the smooth muscles of the uterus to contract.

Mechanical factors These include;

Strength and frequency of Braxton hick‘s contractions occurring in late pregnancy which leads to over stretching of the uterus which irritates the uterine muscles to contract leading to pain.

Pressure of the presenting part on the sacro-nerves and lumbar nerves which has pain receptor.

Pressure of the presenting part on the cervix. The presenting part exerts pressure on the cervix muscles hence leading to pain.

Displacement of the pelvic floor muscles. The advancing presenting part distends the vagina and displaces the pelvic floor muscles which are over stretched and the nerves are compressed leading to pain.

(b) PERCEPTION.

Is the process of becoming aware of the environment through the five senses.

Factors that affect pain perception during labour

These factors are emotional experience involving physical and psychological mechanism and can be contributed by the mother, fetus, health workers and structural environment.

Mother

Maternal medical; conditions like pre-clampsia and eclampsia, cardiac conditions which can affect pain perception.
Compromised immunity due to chronic conditions like HIV and cancer which can affect pain perception.
Size of the pelvis. Any pelvic deviation from normal leading to cephalous pelvic disproportion which can affect pain perception.
Age. Young prime gravidae below 18years their pelvic bones are not fully developed and the mother above 35years their pelvic bones are contracted and this hinders normal progress of labour and affects pain.
Parity. Prime gravidae‘s their muscles are still intact and sensitive to pain which leads to strong contractions. The multipara mothers their muscles are laced which leads to uterine itial.
Past obstetrical history like caesarian section which increases the risks of uterine rapture and affects normal labour
Social economic factors for example lack of support which can affect pain perception.
Cultural factors like use of native drugs can affect pain perception.
Past experience can also affect pain perception
Level of education, occupation, religion can also affect pain perception.

Fetus

Fetal abnormalities like hydrocephalous, macrosomic babies can lead to cephalopelvic disproportion hence affecting pain.
Lie, position and presenting pain can affect pain perception during labour
Size of the fetus that is to say big babies which cannot pass through the pelvis hence affecting pain perception
Gestation age. In past maturity the sutures and the fontanels are closing and molding can hot take place hence affecting pain perception.

Health workers

Poor screening of mothers during antenatal Poor management during labour
Poor attitude towards the mother

Structural environment

Hospital setting where there is no privacy for mothers, all stages of labour in one room which can affect pain perception.
Lack of recreation in labour rooms like newspapers, television to occupy the mothers.

What Questions: Providing Clear Definitions and Explanations

\”What\” questions typically require you to provide clear definitions, explanations, or descriptions of a specific concept, procedure, or pathophysiology These questions aim to test your understanding and knowledge of the subject matter. When answering \”What\” questions, it is important to be precise and concise in your response, while still providing sufficient information to address the question accurately.

Example Question: What is the role of the midwife in the immediate postpartum period?

To answer this question effectively, you can provide a concise definition and description of the midwife\’s role during the immediate postpartum period:

Monitoring maternal and neonatal vital signs: Midwives closely monitor the mother\’s blood pressure, heart rate, and bleeding. They also assess the baby\’s breathing, heart rate, and overall well-being.
Assisting with breastfeeding initiation: Midwives provide support and guidance to initiate breastfeeding, ensuring proper positioning. They offer education on breastfeeding techniques, addressing any concerns or difficulties that may arise.
Providing emotional support: Midwives offer emotional support to new mothers, addressing any anxieties, fears, or questions they may have. They create a nurturing and supportive environment for the mother and her newborn.
Assessing postpartum recovery: Midwives conduct physical examinations to assess the mother\’s postpartum recovery, including uterine involution, healing of perineal tissues, and overall well-being. They provide guidance on self-care practices and postpartum contraception options.
Identifying and managing postpartum complications: Midwives are identify and manage any postpartum complications that may arise, such as postpartum hemorrhage, infection, or breastfeeding difficulties. They collaborate with healthcare providers if further interventions are required.

By explaining the midwife\’s role in the immediate postpartum period, you address the \”What\” question while providing a clear understanding of the topic.

What information must you note on vaginal examination?

On inspection

State of the vulva, note any abnormal discharges like pus, blood, abnormal growths like warts, oedema and scars.

On examination

Note condition of the vagina. Normally the vaginal walls feel warm and moist and dilatable. If dry may be a sign of infection or obstruction.
State of the cervix. If thin, thick, whether soft or rigid and whether its well applied to the presenting part. Note dilatation and cervical effacement.
State of the membranes. Whether intact or ruptured. If ruptured check colour and smell of liquor
Presentation and presenting part. Note level of presenting part in the pelvis. Confirm position by finding or palpating sutures and fontanelles and relate them to the maternal pelvis. Note moulding.
Do internal pelvic assessment and note

-sacro promontary if protruding
-hollow of the sacrum if well curved
-sciatic notches if well rounded
-ischial spines if prominent
-sub pubic arch-if it accommodates 2 ½ to 3 fingers
-inter tuberous diameter if it accommodates 4 knuckles

Tips for Success:

a. Understand the instructions: Carefully read and follow the instructions.

b. Plan your response: Take a moment to brainstorm and outline your ideas before starting to write. This will help you organize your thoughts and ensure a great structured response.

c. Provide relevant examples: Whenever possible, support your answers with real-life examples, or evidence-based practices to demonstrate your understanding and application of midwifery knowledge.

d. Use clear and simple language: Write in a clear and simple manner, avoiding unnecessary elaboration. Focus on delivering information effectively while maintaining clarity.

e. Practice time management: Allocate time for each question based on its difficulty. This will help you ensure that you have enough time to answer all questions within the given time.

f. Review your answers: Before submitting your answer sheet, review your answers to check for any errors, omissions, or areas that need further clarification or elaboration. Don\’t forget to write your NSIN Number!

Question Approach Read More »

Hypertension

Nursing Notes - Thrombus and Embolus

HYPERTENSION

Introduction

Definition: Hypertension, or high blood pressure (BP), is defined as a persistent systolic blood pressure (SBP) greater than or equal to 140 mm Hg, diastolic blood pressure (DBP) greater than or equal to 90 mm Hg. High blood pressure means that the heart is working harder than normal thus putting the heart and the blood vessels on a high pressure.

This is based on the average of two or more accurate blood pressure measurements during two or more consultations with the healthcare provider. The definition is taken from the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Blood pressure: This is the pressure exerted when blood flows into the arteries. It is measured in mmHg using a sphygmomanometer (blood pressure machine).
Diastolic pressure: This is the pressure exerted on the arteries when the heart relaxes.
Systolic pressure: This the pressure exerted on the arteries when the heart contracts.

Types of Hypertension

Primary (essential or idiopathic) hypertension: elevated BP without an identified cause; accounts for 90% to 95% of all cases of hypertension.
Secondary hypertension: elevated BP with a specific cause; accounts for 5% to 10% of hypertension in adults.

Stages of Hypertension

Blood pressure is classified to guide treatment and assess risk.

Category	Systolic BP (mmHg)	Diastolic BP (mmHg)
Normal	less than 120	and less than 80
Elevated	120 – 129	and less than 80
Stage 1 hypertension	130 – 139	or 80 – 89
Stage 2 hypertension	140 or higher	or 90 or higher
Hypertensive crisis	higher than 180	and/or higher than 120

Proper Measurement of Blood Pressure

In order to obtain appropriate results, the following must be followed:

Right Blood Pressure Machine: The cuff should not be too small or too large for the patient.
Rest Period: Allow the patient to rest for at least 5 to 10 minutes before measuring the blood pressure, as exercise increases blood pressure.
Avoid Talking: The patient should not be talking while the blood pressure is being measured, as wrong results (higher) may be obtained when the patient talks.
Arm Position: The arm of the patient should be positioned at the level of the heart.
Multiple Measurements: At least 2-3 measurements should be made at different visits for those with pre-hypertension and stage 1 hypertension before the patient is confirmed to be having hypertension.
Inform Patient: Inform the patient of his or her blood pressure results and what they mean.
Record and Provide Copy: Record the patient’s blood pressure on the medical form, and a copy of results should be given to the patient.

Pathophysiology

There are various mechanisms described for the development of hypertension which includes increased salt absorption resulting in volume expansion, an impaired response of the renin-angiotensin-aldosterone system (RAAS), increased activation of the sympathetic nervous system. These changes lead to the development of increased total peripheral resistance and increased afterload which in turn leads to the development of hypertension.

Causes of Hypertension

Hypertension has a lot of causes just like how fever has many causes. The factors that are implicated as causes of hypertension are:

Increased sympathetic nervous system activity: Sympathetic nervous system activity increases because there is dysfunction in the autonomic nervous system.
Increase renal reabsorption: There is an increase reabsorption of sodium, chloride, and water which is related to a genetic variation in the pathways by which the kidneys handle sodium.
Increased RAAS activity: The renin-angiotensin-aldosterone system increases its activity leading to the expansion of extracellular fluid volume and increased systemic vascular resistance.
Decreased vasodilation of the arterioles: The vascular endothelium is damaged because of the decrease in the vasodilation of the arterioles.

Risk factors of Hypertension

Age: Increasing age increases the risk of development of hypertension
Family History of the disease increases the risk
Lack of exercise
Obesity
Stress and depression
Vitamin D deficiency
Smoking
Drug abuse and alcoholism
Cushing syndrome
Diabetes
Sedentary lifestyle
Intake of extra salt
Insufficient calcium, magnesium, and potassium intake
Chronic kidney disease
Adrenal and thyroid problems
Adrenal gland tumors
Thyroid problems
Certain medications such as birth control pills, cough, and cold remedies and over-the-counter pain relievers( NSAIDs)
Obstructive sleep apnea

Clinical manifestations

Often called the “silent killer” because it is frequently asymptomatic until it becomes severe and target organ disease occurs.

Headache: The red blood cells carrying oxygen is having a hard time reaching the brain because of constricted vessels, causing headache.
Dizziness occurs due to the low concentration of oxygen that reaches the brain.
Chest pain: Chest pain occurs also due to decreased oxygen levels.
Blurred vision: Blurred vision may occur later on because of too much constriction in the blood vessels of the eye that red blood cells carrying oxygen cannot pass through.
Fatigue or confusion,
Lightheadedness,
Vertigo,
Tinnitus,
Fainting,
Irregular heartbeat,
Blood in the urine.

Test and Diagnosis for Hypertension

History exam
Physical exam: Manual checking of blood pressure by a sphygmomanometer.
Urinalysis is performed to check the concentration of sodium in the urine though the specific gravity.
Blood chemistry (e.g. analysis of sodium, potassium, creatinine, fasting glucose, and total and high density lipoprotein cholesterol levels). These tests are done to determine the level of sodium and fat in the body.
Renin level. Renin level should be assessed to determine how RAAS is coping.
Urinalysis: May show blood, protein, or white blood cells; or glucose suggests renal dysfunction and/or presence of diabetes.
Renin: Elevated in renovascular and malignant hypertension, salt-wasting disorders.
Urine steroids: Elevation may indicate hyperadrenalism, pheochromocytoma, pituitary dysfunction, Cushing’s syndrome.
Intravenous pyelogram (IVP): May identify cause of secondary hypertension, e.g., renal parenchymal disease, renal/ureteral -calculi.
Kidney and renography nuclear scan: Evaluates renal status (TOD).
Excretory urography: May reveal renal atrophy, indicating chronic renal disease.

Management

Medical Management

The medications used for treating hypertension decrease peripheral resistance, blood volume, or the strength and rate of myocardial contraction.

For uncomplicated hypertension, the initial medications recommended are diuretics and beta blockers.
Only low doses are given, but if blood pressure still exceeds 140/90 mmHg, the dose is increased gradually.
Thiazide diuretics decrease blood volume, renal blood flow, and cardiac output.
ARBs (Angiotensin II Receptor Blockers) are competitive inhibitors of aldosterone binding.
Beta blockers block the sympathetic nervous system to produce a slower heart rate and a lower blood pressure.
ACE inhibitors inhibit the conversion of angiotensin I to angiotensin II and lowers peripheral resistance.

Drug therapy

ACE Inhibitors (Captopril, Enalapril, Perindopril, Quinapril). an ACE inhibitor is particularly. Useful if heart failure and diabetes present.
Beta-blockers (Acebutolol, Atenolol, Bisoprolol, Propranolol, Timolol). Slowing the heart rate and reducing the force of the heart.
Calcium channel blockers (Amlodipine, DIltiazem, Felodipine, Nifedipine, Verapamil). Relaxing blood vessels and control blood pressure.
Diuretics (Bendroflumethiazide, Chlortalidone, Cyclopenthiazide and Indapamide).

Lifestyle modification

Lifestyle modifications are indicated for all patients with prehypertension and hypertension and include the following:

Weight reduction: A weight loss of 10 kg (22 lb) may decrease SBP by approximately 5 to 20 mm Hg.
Dietary Approaches to Stop Hypertension (DASH) eating plan. Involves eating several servings of fish each week, eating plenty of fruits and vegetables, increasing fiber intake, and drinking a lot of water. The DASH diet significantly lowers BP.
Restriction of dietary sodium to less than 6 g of salt (NaCl) or less than 2.4 g of sodium per day. This involves avoiding foods known to be high in sodium (e.g., canned soups) and not adding salt in the preparation of foods or at meals.
Restriction of alcohol
Regular aerobic physical activity (e.g., brisk walking) at least 30 minutes a day most days of the week. Moderately intense activity such as brisk walking, jogging, and swimming can lower BP, promote relaxation, and decrease or control body weight.
It is strongly recommended that tobacco use be avoided.
Stress management. Stress can raise BP on a short-term basis and has been implicated in the development of hypertension. Relaxation therapy, guided imagery, and biofeedback may be useful in helping patients manage stress, thus decreasing BP.

Nursing management

1. Assessment of the patient

a. Carrying out history of the presenting signs and symptoms e.g. fever, headaches among others.
b. Taking vital observation e.g. TPR/BP and general examination to exclude other diseases
c. Alerting the doctor who will order for investigations and admission, there the nurse will assist the patient throughout the process

2. To prevent the heart failure as a result of BP > 140 systolic

a. Monitor bp. Measure in both arms/thighs three times, 3–5 min apart while patient is at rest, then sitting, then standing for initial evaluation. Use correct cuff size and accurate technique.
b. Note presence, quality of central and peripheral pulses because pulses in the legs/feet may be diminished, reflecting effects of vasoconstriction increased systemic vascular resistance and venous congestion.
c. Auscultate heart tones and breath sounds to detect pulmonary congestion secondary to developing or chronic heart failure.
d. Observe skin color, moisture, temperature, and capillary refill time to detect or exclude peripheral vasoconstriction.

3. To relieve pain (head ache among others)

a. Determine specifics of pain, e.g., location, characteristics, intensity (0–10 scale), onset/duration and note nonverbal cues to identify the pain
b. Encourage/maintain bed rest during acute phase to minimizes stimulation/promotes relaxation.
c. Provide/recommend non-pharmacological measures for relief of headache, e.g., cool cloth to forehead; back and neck rubs; quiet, dimly lit room; relaxation techniques (guided imagery, distraction); and diversional activities to reduce cerebral vascular pressure.

4. Diet

a. Establish a realistic weight reduction plan with the patient, e.g., 1 lb weight loss/wk.
b. Instruct and assist in appropriate food selections, such as a (DASH diet) diet rich in fruits, vegetables, and low-fat dairy foods referred to as the dash dietary approaches to stop hypertension) diet and avoiding foods high in saturated fat (butter, cheese, eggs, ice cream, meat) and cholesterol (fatty meat, egg yolks, whole dairy products, shrimp, organ meats).

5. To promote patient’s knowledge:

a. Instruct patient and family about the cause, management of symptoms, signs, and symptoms, and the need for follow-up.
b. Instruct patient about the factors that may have contributed to the development of the disease.

6. Discharge and Home Care Guidelines

a. The nurse can help the patient achieve blood pressure control through education about managing blood pressure.
b. Assist the patient in setting goal blood pressures.
c. Encourage the involvement of family members in the education program to support the patient’s efforts to control hypertension.
d. Encourage and teach patients to measure their blood pressures at home.
e. Emphasize strict compliance of follow-up checkup.

Complications of Hypertension

Heart attack or stroke,
Aneurysm,
Weakened and narrowed blood vessels of the kidney,
Heart failure,
Thickened narrowed or torn blood vessels of eyes (Blindness),
Metabolic syndrome.

Drug Therapy for Hypertension

Drug treatment is recommended for those patients who have not responded to non-drug measures and for those who report when the blood pressure is already very high. One drug (monotherapy) is recommended initially for patients with mild hypertension.

In case of poor response, another drug may be added or substituted.

Patients who present when already in stage 2 hypertension may be started on two drugs at once in lower doses, then adjusted depending on the response.

Choice of Antihypertensive

When choosing a drug for treating hypertension, consider the following in order to safely use the drugs and effectively control blood pressure:

Co-existing Diseases/Conditions: Patients with other existing diseases or conditions such as pregnancy, asthma, diabetes, heart failure, and angina pectoris. This is because some antihypertensives are not recommended to be used in some of the above conditions.
Affordability and Accessibility: Ensure affordability and accessibility of the medicine by the patients.
Allergies: Establish whether the patient is allergic to the drug or not.
Target Organ Damage: Establish the presence of target organ damage.

Choice of Antihypertensive in Different Conditions

Condition	1st Choice	2nd Choice
Pregnancy	Methyldopa (Aldomet)	Atenolol, Nifedipine
Diabetes Mellitus	Captopril, Lisinopril	Nifedipine, Amlodipine
Asthma	Amlodipine, Nifedipine
Preeclampsia or Eclampsia of Pregnancy	Hydralazine (Apresoline)	Labetalol
Angina Pectoris	Nifedipine, Amlodipine	Atenolol, Propranolol
Heart Failure	Frusemide, Lisinopril, Captopril	Carvedilol

Resistant Hypertension

This is the persistent elevation of blood pressure above 140/90mmHg despite the use of 3 or more appropriate drug combinations including a diuretic at full doses.

Causes:

Patients above 60 years
Poor drug compliance (taking the drugs wrongly)
Continuous presence of risk factors such as smoking, excessive alcohol intake, and obesity
Concurrent use of drugs that elevate blood pressure, for example, flu (common cold) preparations (decongestants), painkillers like diclofenac
Presence of secondary causes of hypertension, for example, kidney failure

Malignant Hypertension, Hypertensive Emergency, Hypertensive Urgency

Malignant Hypertension

Malignant hypertension is a condition characterized by a sudden severe rise in blood pressure resulting in small vessel damages.

Clinical Presentation:

Confusion
Headache
Visual loss
Coma

It is a medical emergency that requires hospital admission and rapid control of blood pressure over 12 to 24 hours to a normal level.

Hypertensive Emergency

This is a severe elevation of blood pressure (more than 180/120mmHg) with signs of damage to target organs such as the brain and kidney.

The patient must be admitted to the hospital, if possible in an intensive care unit, and pressure must be lowered immediately to prevent damage to the kidney, heart, and brain.

Blood pressure should be gradually lowered since cerebral hypoperfusion can occur if the blood pressure is lowered by more than 40% in the initial 24 hours.

Drugs used to treat hypertensive emergencies in Uganda include intravenous hydralazine or Labetalol.

Hypertensive Urgency

This is a situation in which blood pressure is very elevated but there is no potential organ damage.

The blood pressure must be reduced within 1-2 days, and oral medications are recommended, for example, Nifedipine (Sublingual), Captopril, Labetalol tablet, etc.

Drugs Used in the Treatment of Hypertension

Drugs used in the treatment of hypertension in Uganda include:

Beta blockers
Calcium channel blockers
Diuretics
Angiotensin converting enzyme inhibitor (ACE inhibitors)
Angiotensin II antagonist
Centrally acting antihypertensive
Direct acting vasodilators

1. Beta Blockers

Beta blockers are the most commonly used drugs in the treatment of hypertension in Uganda because they are affordable and available in most places countrywide.

Examples:

Propranolol (Inderal)
Atenolol (Totamol)
Carvedilol
Labetalol

Mechanism of Action:

Beta blockers block beta 1 receptors in the heart, which results in slowing of the heart rate and reduction in the force of heart contraction. This action results in lowering of blood pressure.

Indications:

Hypertension
Angina pectoris
Migraine headache
Congestive heart failure (Carvedilol)
Post myocardial infarction

Side Effects:

Impotence
Wheezing
Cold extremities
Bradycardia
Reduced exercise tolerance
Tiredness
Heart failure

Contraindications:

Patients with asthma
Patients with acute heart failure
Heart block
Chronic obstructive airway disease
Patients with diabetes mellitus (since they mask signs of hypoglycemia)
Depression
Pregnancy and breast feeding

Generally, common beta blockers are recommended for use in pregnant mothers, though prolonged use may lead to growth retardation in fetuses. Beta blockers may be used in breast feeding mothers.

2. Calcium Channel Blockers

Calcium channel blockers are among the first-line drugs used in the treatment of hypertension. They can be used alone or in combination with other antihypertensives such as beta blockers, Angiotensin converting enzyme inhibitors, or diuretics. These drugs can be used safely in patients who also have other co-existing conditions such as asthma, hyperlipidemia, diabetes mellitus, and renal dysfunction.

Examples:

Nifedipine
Amlodipine
Felodipine

Mechanism of Action:

Calcium channel blockers decrease the entry of calcium ions into the smooth muscles, causing vasodilation and lowering of the blood pressure.

Indications:

Hypertension
Angina pectoris

Side Effects:

Flushing
Oedema
Headache
Postural hypotension
Dizziness
Weakness
Heart burn
Tachycardia

Contraindications:

2nd or 3rd degree heart block
Known hypersensitivity to any of the members
Severe heart failure
Severe hypotension
Pregnancy and breast feeding

Calcium channel blockers, especially Nifedipine, are used in the treatment of hypertension in pregnant mothers.

3. Diuretics

Diuretics are among the first-line drugs used in the treatment of hypertension. Diuretics, for example Bendrofluazide, are safe, cheap, and effective in the treatment of hypertension. These drugs may be used alone or in combination with ACE inhibitors, beta blockers, etc., in the treatment of hypertension.

Classification of Diuretics:

Class	Example
Thiazide Diuretics	Bendrofluazide (Aprinox), Metolazone
Loop Diuretics	Frusemide (Lasix)
Potassium Sparing Diuretics	Spironolactone

Mechanism of Action:

Diuretics work by promoting the excretion of large amounts of water in the form of urine, thereby reducing the blood volume and lowering of blood pressure.

Indications:

Hypertension
Heart failure

Note: Thiazide diuretics are mainly used in the treatment of hypertension but may be used in mild cases of heart failure. Loop diuretics are commonly used in the treatment of heart failure and rarely in the treatment of hypertension unless associated with fluid overload (oedema).

Side Effects:

Class	Common Side Effects
Thiazide Diuretics	Hypokalaemia, Hyperuricaemia (elevated level of uric acid), Glucose intolerance, Sexual dysfunction (impotence), Weakness, Dehydration
Loop Diuretics	Dehydration, Dry mouth, Muscle aches, Hypokalaemia, Elevation of blood sugar, Postural hypotension

Contraindications:

Thiazide diuretics are not recommended in patients with:

Gout
Diabetes
Hypokalaemia
Hyperlipidemia
Known hypersensitivity

Pregnancy and Breastfeeding:

Generally, diuretics should be used with caution during pregnancy and breastfeeding.

4. Angiotensin Converting Enzyme Inhibitors (ACE Inhibitors)

ACE inhibitors are drugs of first choice in the treatment of hypertension and also hypertension in diabetic patients. They may be used alone or in combination with diuretics or beta blockers.

Examples:

Captopril
Ramipril
Lisinopril
Enalapril

Mechanism of Action:

These drugs interfere with the conversion of Angiotensin I (vasodilator) to Angiotensin II (vasoconstrictor) by inhibiting the Angiotensin converting enzyme. This leads to a reduction of peripheral resistance and lowering of blood pressure.

Indications:

Hypertension
Heart failure
Diabetic nephropathy

Side Effects:

The common side effects associated with the use of ACE inhibitors include:

Dry irritating cough
Skin rash
Taste disturbance
Angioedema

Contraindications:

Pregnant mothers
Patients with renal impairment
Previous history of angioedema
Known hypersensitivity to any of the drugs in this group
Breastfeeding

5. Centrally Acting Antihypertensives

These drugs were among the first to be used in the treatment of hypertension in Uganda. They are no longer used so much in the general management of hypertension because of associated side effects and presence of effective drugs with less side effects.

Examples:

Methyldopa
Clonidine

Methyldopa, the only member currently registered in Uganda, is used as a drug of 1st choice in the treatment of hypertension in pregnant mothers because of its safety in this category of patients.

Mechanism of Action:

These drugs inhibit sympathetic outflow from the brain, thereby decreasing total peripheral resistance and lowering of blood pressure.

Indications:

Hypertension during pregnancy
Severe hypertension as a 3rd line drug

Side Effects:

Tiredness
Headache
Impotence
Dizziness
Mental depression
Sedation
Rebound hypertension on withdrawal

Contraindications:

Severe liver disease
Known hypersensitivity to methyldopa

6. Angiotensin II Antagonists

These drugs are among the new ones used in the treatment of hypertension. They are as effective as ACE inhibitors but are usually recommended in patients who cannot tolerate ACE inhibitors because of side effects such as cough.

Examples:

Losartan
Telmisartan
Valsartan
Candesartan

Mechanism of Action:

Angiotensin II antagonists bind tightly at Angiotensin II receptors, preventing the action of Angiotensin II. This action reduces peripheral resistance, resulting in vasodilation and lowering of blood pressure.

Indications:

Hypertension
Heart failure

Side Effects:

The most common side effects associated with the use of these drugs include:

Hypotension
Dizziness
Hyperkalaemia

Contraindications:

These drugs should be avoided during pregnancy, especially during the 2nd and 3rd trimester, since they are associated with fetal malformation.

Breastfeeding mothers

7. Direct Acting Vasodilators

Drugs that belong to this group include:

Hydralazine
Minoxidil

Hydralazine is the only member registered in Uganda and is only recommended in the treatment of hypertension that has not responded to other antihypertensives.

The use of hydralazine in the long-term treatment of hypertension is associated with fluid retention and reflex tachycardia, which can be offset by combining it with beta blockers (to prevent reflex tachycardia) or diuretics (to reduce fluid retention).

Mechanism of Action:

Direct acting vasodilators work directly on the blood vessels causing relaxation (widening of the blood vessel) leading to a reduction in the blood pressure.

Indications:

Severe hypertension
Hypertensive emergencies
Hypertension in pregnancy associated with pre-eclampsia and eclampsia

Side Effects:

The following side effects are commonly seen when hydralazine is used:

Headache
Tachycardia
Flushing
Dyspnoea
Oedema
Postural hypotension

Contraindications:

Angina pectoris
Patients with heart failure
Known hypersensitivity

Hypertension Read More »

Mood Stabilizers

Mood Stabilizers: Comprehensive Pharmacotherapy

Mood stabilizers are a class of psychotropic medications primarily used to treat bipolar affective disorder (BAD) and other conditions involving severe mood swings or instability. They help control the frequent fluctuation of mood at short intervals and are utilized as maintenance drugs to prevent relapses.

Mood stabilizers are psychotropic drugs which are used in controlling mood disorders. They are essential for managing the extreme highs and lows associated with bipolar disorders and related psychiatric conditions.

I. Introduction & History

Definition

No consensus definition: Officially, the FDA states, "There is no such thing as a mood stabilizer."
Clinical Definition (Sachs, 1996): Any medication that is able to decrease vulnerability to subsequent episodes of mania or depression; and does not exacerbate the current episode or maintenance phase of treatment.
Important Rule: Patients with acute-phases of mania or depression should generally be treated first with anti-psychotics or anti-depressants respectively, alongside or before transitioning to maintenance mood stabilizers.

Brief History & Trivia

1817: Lithium was discovered as a chemical element.
1871: First recorded use as a treatment of mania.
1876: Li₂CO₃ used in the prevention of depression.
Early 20th Century: Use of Lithium largely abandoned due to its severe toxicity.
1949: Use of Lithium for mania rediscovered by Australian psychiatrist John Cade.
1970: FDA approved the use of Lithium for mania.
1995: Sodium valproate approved for acute mania.

Trivia: The popular soft drink "7 Up" originally contained Lithium citrate from 1929 to 1950 and was marketed as a good remedy for relieving alcoholic hangovers!

II. Pathophysiology & General Mode of Action

The exact mode of action of mood stabilizers is not fully understood, but three primary pharmacological theories explain their efficacy:

Neurotransmitter Regulation: Mood stabilizers regulate the levels of monoamine neurotransmitters (serotonin, dopamine, and norepinephrine). Imbalances lead to mood swings. Mood stabilizers normalize these imbalances, reducing bipolar symptoms.
Ion Channel Modulation (Voltage-Sensitive Channels): They modulate the activity of voltage-gated ion channels, particularly sodium (Na⁺) and calcium (Ca²⁺) channels. These channels regulate neuronal excitability. Abnormal activity leads to mania or depression; stabilization reduces this aberrant firing.
Structural and Signal Transduction Modulation: They affect the structure and function of brain regions regulating mood (prefrontal cortex, amygdala) by acting on downstream signal transduction cascades (e.g., G-proteins, second messengers like inositol monophosphate, and enzymes like GSK-3 and PKC), promoting neuroprotection and long-term neuroplasticity.

III. Classification of Drugs Used as Mood Stabilizers

Lithium: The gold standard element.
Anticonvulsants: Carbamazepine, Sodium Valproate, Lamotrigine, Gabapentin, Pregabalin, Topiramate.
Atypical Antipsychotics: Olanzapine, Quetiapine, Risperidone, Aripiprazole.

IV. Lithium Carbonate (Eskalith, Lithobid)

Lithium is a naturally occurring element. It is the classic mood stabilizer, possessing profound anti-manic and anti-suicidal properties.

Lithium carbonate is a medication that is commonly used as a mood stabilizer to treat bipolar disorder. It is a naturally occurring element that is found in small amounts in the body, and it works by affecting the levels of certain neurotransmitters in the brain, particularly serotonin and norepinephrine.

1. Indications for Use

Acute treatment of mania.
Prophylaxis of bipolar affective disorder (More effective in preventing manic relapses than depressive relapses).
Augmentation of antidepressants in treatment-resistant unipolar depression.
Prevention of aggressive behavior in patients with learning difficulties or personality disorders.
Schizoaffective disorder and Alcoholism.

Lithium and Suicide: The estimated suicide rate in bipolar patients is 10-15%. Lithium is unique among psychiatric drugs as it reduces both attempted and completed suicide by a staggering 80%.

2. Mechanism of Action

Exact mechanism is uncertain, but it works by affecting signal transduction:

Through the inhibition of 2nd messenger enzymes (e.g., inositol monophosphate).
By modulation of G proteins.
By interaction at various sites within downstream signal transduction cascades (e.g., inhibition of Glycogen Synthase Kinase-3 [GSK3] and Protein Kinase C [PKC]).
Cerebral sodium concentration is reduced, which helps control mania and reduces excitements.

3. Pharmacokinetics & Dosing

Dosage

For adults:

The typical starting dose of lithium carbonate for the treatment of bipolar disorder is 300-600 mg per day, divided into two or three doses.
The dosage is then gradually increased, usually by 300-600 mg per week, until a therapeutic blood level is achieved.
Maintenance doses of lithium carbonate can range from 600-2400 mg per day, depending on the individual’s needs and the therapeutic blood level.

For children:

Lithium carbonate is not typically prescribed for children under the age of 12, as there is limited research on its safety and efficacy in this population.
For adolescents aged 12-18, the starting dose of lithium carbonate is 300 mg per day, divided into two or three doses.
The dosage is then gradually increased as needed, usually by 150-300 mg per week, until a therapeutic blood level is achieved.

4. Pre-treatment Tests & Monitoring

Lithium has a very narrow therapeutic index. Monitoring is critical for patient survival.

Test / Parameter	Details & Frequency
Pre-Lithium Workup	Renal functions (BUN, Creatinine, GFR), Thyroid functions (TFTs), ECG (for cardiac risks), FBS, electrolytes, complete blood count (CBC), Urinalysis, Pregnancy test.
Plasma Level Monitoring	Check at 1st 4-7 days → 2 weekly until satisfactory → 6 weekly → 3 monthly when stable. Blood drawn 12-14 hours post-dose.
Therapeutic Plasma Levels	Prophylaxis: Minimum effective: 0.4 mmol/L. Optimal range: 0.6 - 0.75 mmol/L (up to 1.2 mEq/L). Acute Mania: 0.8 - 1.0 mmol/L (up to 1.2 mEq/L). Toxic Level: > 1.5 mmol/L (Early), > 2.0 mmol/L (Serious/Lethal).
Long-term Routine Tests	GFR and TFTs every 6 months.

Routine Investigations

Note: When one is on lithium carbonate, the following base line investigations should be done:

Blood serum lithium level:
- The normal range 0.6-1.2 mEq/l (for prevention of relapse in BAD).
- Therapeutic levels 0.8-1.2mEq/l (for treatment of acute mania).
- Toxic lithium levels greater than 2.0 mEq/l.
Blood tests: A complete blood count (CBC) and blood chemistry panel should be done to assess the person’s overall health and to check for any underlying medical conditions that could affect their response to lithium. The blood chemistry panel should include tests for electrolyte levels (including sodium and potassium), kidney function, liver function, and thyroid function.
Urinalysis: A urinalysis should be done to assess kidney function and to check for any signs of kidney damage.
ECG: An electrocardiogram (ECG) should be done to assess the person’s heart function and to check for any underlying cardiac conditions that could affect their response to lithium.
Pregnancy test: Women of childbearing age should have a pregnancy test before starting lithium, as this medication can be harmful to a developing fetus.
Medical history: A thorough medical history should be taken to assess the person’s overall health, including any past or current medical conditions, medications, or allergies.
Psychiatric evaluation: A comprehensive psychiatric evaluation should be done to assess the person’s symptoms and to establish a diagnosis of bipolar disorder.
Baseline mood assessment: A baseline assessment of the person’s mood and behavior should be done to establish a baseline for monitoring the effects of the medication.

N.B: A patient on lithium carbonate should also be given a thyroxin tablet (also known as levothyroxine), a medication that is used to treat an underactive thyroid gland (hypothyroidism). This is because lithium can affect the functioning of the thyroid gland.

5. Side Effects

Lithium carbonate is generally well-tolerated when used as a mood stabilizer for the treatment of bipolar disorder. However, like any medication, it can cause side effects, both in the short term and the long term.

Short-term side effects of lithium can include:

Nausea, vomiting, and diarrhea
Dry mouth and thirst
Increased urination
Muscle weakness and tremors
Fatigue and drowsiness
Headaches
Increased appetite and weight gain
Mild cognitive impairment (difficulty with attention, memory, or problem-solving)
Skin rash or acne
Vertigo
Dysarthria (impaired articulation of speech)
Cardiac arrhythmias
In some patients they may have oedema
Nystagmus

Many of these side effects are usually mild and may resolve on their own as the body adjusts to the medication. Some people may be able to manage these side effects by adjusting the dosage or timing of their medication, or by taking it with food or milk.

Long-term use of lithium can cause more serious side effects, including:

Kidney damage or kidney failure
Hypothyroidism (underactive thyroid gland) i.e. reduced thyroxin in the body as lithium carbonate interferes with metabolism
Increased risk of diabetes mellitus
Cardiovascular disease (heart disease)
Neurological effects (such as hand tremors, slurred speech, and impaired coordination)
Teratogenicity (birth defects in fetuses exposed to lithium during pregnancy)
Nephrogenic diabetes insipidus
Depletion of calcium in bones
Memory impairment affects memory centers of the brain.

NB: Big doses of neuroleptics e.g. haloperidol when used together with lithium for a long time may cause irreversible toxic encephalopathy.

Mnemonic: LITHIUM Side Effects

L - Leukocytosis (Reversible increase in WBCs)
I - Insipidus (Nephrogenic Diabetes Insipidus - polyuria/polydipsia due to blocking of ADH)
T - Tremor (Fine hand tremors) & Teratogenicity (Ebstein's anomaly in 1st trimester)
H - Hypothyroidism & Hyperparathyroidism (Hypercalcemia)
I - Increased weight (especially in women) / Interstitial nephritis (Rare)
U - Urine output increased (Polyuria)
M - Metallic taste / Mouth dry / Memory impairment

Contraindications of Lithium Carbonate

Allergies: People who are allergic to lithium carbonate or any of its ingredients should not take this medication.
Kidney disease: Lithium is primarily excreted by the kidneys, and people with kidney disease may be at risk of toxicity if they take lithium. Lithium is contraindicated in people with severe kidney disease or end-stage renal disease.
Dehydration: Lithium can affect the body’s electrolyte balance, particularly sodium, and dehydration can increase the risk of toxicity. People who are dehydrated or at risk of dehydration should not take lithium.
Cardiovascular disease: Lithium can affect the cardiovascular system, and people with a history of heart disease or other cardiovascular conditions may be at increased risk of complications if they take lithium.
Pregnancy and breastfeeding: Lithium can cross the placenta and pass into breast milk, and it may be harmful to a developing fetus or nursing infant. Lithium is contraindicated during pregnancy and breastfeeding, unless the benefits outweigh the risks (Note: known to cause Ebstein's anomaly).
Low sodium levels: Lithium can cause or worsen hyponatremia (low sodium levels in the blood), which can be life-threatening. Lithium is contraindicated in people with severe or uncontrolled hyponatremia.
Seizures: Lithium can lower the seizure threshold, and it is contraindicated in people with a history of seizures or epilepsy.
Thyroid disease: Lithium can affect thyroid function and may exacerbate hypothyroidism (an underactive thyroid). Lithium is contraindicated in people with severe hypothyroidism.

6. Lithium Toxicity & Management

> 1.5 mmol/L (Early toxic effects): GI effects (increasing anorexia, nausea, vomiting, diarrhea), CNS effects (muscle weakness, drowsiness, ataxia, coarse tremor, poor coordination, slurring of speech, confusion, muscle twitching).
> 2.0 mmol/L (Serious toxic effects): Disorientation, seizures, coma, death. Irreversible toxic encephalopathy can occur, especially if combined with high-dose neuroleptics (e.g., haloperidol).

Risk Factors for Toxicity:

Mostly involve reduced plasma Na (Sodium) levels. The kidney cannot easily differentiate Lithium from Sodium. If Sodium drops, the kidney reabsorbs Lithium, causing fatal toxicity.

Low salt diet or Dehydration (heavy sweating, outdoor labor).
Drug interactions: Diuretics (esp. Thiazides), NSAIDs, ACE inhibitors, Angiotensin II receptor blockers (ARBs), and some antibiotics like metronidazole.

Management of Toxicity:

Stop taking lithium: The person should stop taking lithium immediately to prevent further toxicity.
Assess serum lithium levels, electrolytes, renal functions, ECG.
Fluid and electrolyte replacement: Intravenous fluids may be given to help flush out the excess lithium from the body and to restore electrolyte balance.
Supportive care: The person may need to be hospitalized for close monitoring of their vital signs and mental status. In severe cases, mechanical ventilation and dialysis may be necessary.
Extra NaCl to stimulate osmotic diuresis and compete with lithium reabsorption.
Pharmacological treatment: Depending on the severity of the symptoms, the person may be given medications to help control nausea, vomiting, seizures, or other symptoms.
Gastric lavage, emesis, or activated charcoal for acute short-time ingestion.
If level > 3.0 mmol/L (or severe symptoms): Peritoneal dialysis or Haemodialysis is indicated to wash the lithium out of the blood.

Lithium Discontinuation:

There is a high risk of manic relapse (even in patients symptomless for 5 years). It is recommended not to start Lithium without an intention to continue for at least 3 years. Discontinuation should be done slowly over at least 1 month.

NURSE’S RESPONSIBILITIES FOR PATIENT RECEIVING LITHIUM

Assessment: Nurses should perform a thorough assessment of the patient before starting lithium treatment, including a physical examination, medical history, and laboratory tests to establish baseline values. Nurses should also monitor the patient regularly for potential side effects or adverse reactions.
Education: Nurses should educate the patient and their family members about the proper use of lithium, including the dosage, timing, and potential side effects. They should also instruct the patient to avoid dehydration and to maintain a consistent level of sodium intake.
Medication administration: Nurses should administer lithium carbonate according to the prescribed dosage and timing. They should also monitor the patient’s compliance with the medication regimen and report any missed doses or concerns to the healthcare provider.
Monitoring: Nurses should monitor the patient regularly for potential side effects or adverse reactions, such as tremors, confusion, or kidney dysfunction. They should also monitor the patient’s blood levels of lithium, electrolytes, and kidney function regularly and report any abnormalities to the healthcare provider.
Collaboration: Nurses should collaborate with the healthcare provider and other members of the healthcare team to ensure the safe and effective use of lithium carbonate. They should also communicate any concerns or changes in the patient’s condition to the healthcare provider in a timely manner.

Precautions to achieve therapeutic effect and prevent lithium toxicity:

Lithium must be taken on regular basis, preferably at the same time daily. For example, a client taking lithium on TID schedule, who forgets a dose, should wait until the next scheduled time to take lithium and not take twice the amount at one time, because lithium toxicity can occur.
When lithium therapy is initiated, mild side effects such as fine tremors, increased thirst and urination, nausea, anorexia etc may develop.
Serious side effects of lithium that necessitate its discontinuance include vomiting, extreme hand tremors, sedation, muscle weakness and vertigo. The psychiatrist should be notified immediately if any of these effects occur.
Since polyurea can lead to dehydration with risk of lithium intoxication, patients should be advised to drink water to compensate for the fluid loss.
Various situations can require an adjustment in the amount of lithium administered to a client, such as the addition of a new medicine to the client’s drug regimen, a new diet or an illness with fever or excessive sweating. People involved in heavy outdoor labor are prone to excessive sweating and sodium loss through sweating. Must be advised to consume large quantities of water with salt, to prevent lithium toxicity due to decreased sodium levels.
Frequent serum lithium level evaluation is important. Blood for determination of lithium levels should be drawn in the morning approximately 12-14 hours after the last dose was taken.
The patient should be told about the importance of regular follow up. In every six months, a blood sample should be taken for estimation of electrolytes, urea, creatinine, a full blood count, and thyroid function test.

V. Anticonvulsant Mood Stabilizers

1. Sodium Valproate (Epilim / Depakote)

An anticonvulsant that acts as a highly effective mood stabilizer. Believed to be more effective than Lithium in treating rapid cycling and mixed episodes of mania.

Sodium valproate is a medication used to treat a variety of neurological and psychiatric conditions. It belongs to a class of drugs called anticonvulsants, which are typically used to treat epilepsy, but sodium valproate has also been found to be effective in treating bipolar disorder, migraine headaches, and certain types of seizures.

Indications of Sodium Valproate

Epilepsy: Used to prevent and control seizures in patients with epilepsy, including generalized and partial seizures, absence seizures, and myoclonic seizures.
Bipolar disorder: Used as a mood stabilizer in the treatment of bipolar disorder, which is characterized by episodes of mania and depression.
Migraine prophylaxis: Sometimes used to prevent migraines, particularly in patients who do not respond to other treatments.
Neuropathic pain: May be used to treat certain types of neuropathic pain, such as trigeminal neuralgia and diabetic neuropathy.
Agitation and aggression: May be used to treat agitation and aggression in patients with dementia, autism, or other psychiatric conditions.
Alcohol withdrawal: May be used to treat alcohol withdrawal symptoms, such as seizures and delirium tremens.
Treatment of acute mania, prophylaxis of bipolar disorder, Epilepsy (all forms, drug of choice in myoclonic seizures), migraine prophylaxis, neuropathic pain, agitation in dementia, alcohol withdrawal. Shown to be useful for patients unresponsive to Lithium and Carbamazepine.

Mode of Action

Sodium valproate works by increasing the levels of a neurotransmitter called gamma-aminobutyric acid (GABA) in the brain (by inhibiting GABA transaminase), which helps to calm overactive neurons and prevent seizures. It also blocks voltage-gated sodium channels. It has mood-stabilizing properties that make it effective in treating bipolar disorder.

90% bound to plasma albumin. Three possibilities:

Inhibition of voltage-sensitive Na+ channels (VSSC) – Diminishes excitatory glutamate neurotransmission.
Enhancing actions of GABA – Promotes inhibitory neurotransmission by inhibiting GABA transaminase (the enzyme that breaks down GABA).
Regulating downstream signal transduction cascades – Promotes neuroprotection and long-term plasticity.

Dosage

For Epilepsy:
- Adults: Usual starting dose is 600-1000 mg per day, divided. Maintenance up to 2500-3000 mg per day.
- Children: Starting dose is usually 10-15 mg/kg/day. Maintenance up to 30-60 mg/kg/day.
- Elderly: Starting dose may be lower, around 250-500 mg per day. Maintenance up to 2000 mg per day.
For Bipolar Disorder:
- Adults: Starting dose is usually 500-750 mg per day, divided. Maintenance up to 2000-2500 mg per day.
- Children: Starting dose is usually 10-15 mg/kg/day. Maintenance up to 60 mg/kg/day.
- Elderly: Starting around 250-500 mg per day. Maintenance up to 2000 mg per day.

Side Effects

Gastrointestinal effects: Nausea, vomiting, diarrhea, and abdominal pain are common.
Weight gain: Can cause weight gain and changes in appetite.
Sedation and drowsiness: Can affect the ability to operate machinery or drive.
Tremor: Involuntary movements of the hands, arms, or other body parts.
Hair loss (Alopecia): Can cause hair loss, although this side effect is usually reversible.
Liver toxicity (Hepatotoxicity): Can cause severe liver toxicity, especially those taking other medications affecting the liver. Requires LFT monitoring.
Blood disorders: Can affect blood cells, leading to anemia, low platelet counts (thrombocytopenia), and increased risk of bleeding.
Pancreatitis: In rare cases, can cause severe inflammation of the pancreas, a potentially life-threatening condition.

Contraindications

Hypersensitivity: Should not be used in patients who have had an allergic reaction.
Liver disease: Can cause liver toxicity, so it should be avoided in patients with pre-existing liver disease or abnormal LFTs.
Pancreatitis: Should not be used in patients with a history of pancreatitis.
Pregnancy: Can cause severe birth defects (e.g., neural tube defects like spina bifida) and developmental problems. Avoided in pregnant women.
Breastfeeding: Passes into breast milk and can harm a nursing baby.
Urea cycle disorders: Can cause fatal hyperammonemia in patients with urea cycle disorders.

Adverse Effects

GI disturbances, tremor, sedation, tiredness (common).
Weight gain & Transient hair loss (alopecia).
Hepatotoxicity: Elevation of liver enzymes.
Hematologic: Thrombocytopenia, inhibition of platelet aggregation, anemia.
Pancreatitis: Acute, potentially life-threatening.
Polycystic ovarian disease (PCOS) & Rashes.
Teratogenicity: Spina bifida, ASD, cleft palate, hypospadias, polydactyly, craniosynostosis.

2. Carbamazepine (Tegretol)

Carbamazepine is a medication used primarily to treat seizures and nerve pain, such as trigeminal neuralgia. It works by reducing the excessive electrical activity in the brain that can cause seizures and by reducing the sensitivity of nerve fibers, which can help to relieve pain. Carbamazepine belongs to a class of medications called anticonvulsants, which are also used to treat bipolar disorder and mood disorders.

Mechanism of Action:

Blocks voltage-sensitive Na+ channels (VSSC) at a site within the channel on the alpha subunit.
Reduces glutamate release.
Decreases turnover of norepinephrine and dopamine.
Facilitates 5HT (serotonin) neurotransmission.

Pharmacological Note: It acts by prolonging the inactivated state of voltage-gated sodium channels. It also exhibits auto-induction of hepatic CYP450 enzymes.

Indications

In epilepsy especially in complex partial seizure (drug of choice).
Rapid cycling bipolar disorder.
Acute mania.
Trigeminal neuralgia i.e. inflammation of the trigeminal nerve (absolute drug of choice).
Herpes zoster (post-herpetic neuralgia).
Schizoid affective disorder.

Dosage

Children: Starting dose for epilepsy is usually 10-20 mg/kg/day, divided. Max 1000 mg/day. For trigeminal neuralgia, 100 mg/day divided.
Adults: Starting dose for epilepsy is usually 200-400 mg/day, divided into two or three doses. Max 1200 mg/day. For trigeminal neuralgia, 100-200 mg/day.
Elderly: Starting dose may be lower due to age-related changes in metabolism and potential for side effects. Carefully monitor and adjust.

Side Effects

Dizziness or drowsiness.
Nausea or vomiting.
Headache.
Blurred vision or double vision (diplopia).
Skin rash or itching.
Dry mouth, constipation, or diarrhea.
Swelling or fluid retention (edema).
Unsteadiness (ataxia) or loss of coordination, fatigue, weakness.

Severe Adverse Effects

More serious adverse effects may occur with carbamazepine, and require immediate medical attention. These can include:

Severe skin reactions: such as Stevens-Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN). (HLA-B*1502 genetic testing is recommended for at-risk Asian populations).
Blood disorders: such as agranulocytosis or aplastic anemia.
Liver damage or hepatitis.
Allergic reactions, including anaphylaxis.
Increased risk of suicidal thoughts or behaviors.
Drug Interactions: It induces liver enzymes, causing birth control pills (oral contraceptives) to be less effective, leading to unintended pregnancies.
Drowsiness, dizziness, ataxia, diplopia (double vision), nausea – common at beginning.
Hematologic: Agranulocytosis (Rare 1:10000 to 1:25000), Relative leucopenia (common), aplastic anemia.
Dermatologic: Rashes (5%), Severe skin reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis).
Hepatic & Endocrine: Elevation of LFTs (Hepatitis - rare), reduces plasma thyroxin level (clinical hypothyroidism is rare).
Disturbance of cardiac conduction.
Teratogenicity: Neural tube defects. Causes birth control pills to be less effective (CYP450 inducer).

Contraindications

Hypersensitivity or allergy: to carbamazepine or tricyclic antidepressants.
Bone marrow suppression: Can cause a decrease in blood cell production. Do not use in individuals with blood disorders.
History of agranulocytosis: A severe decrease in white blood cells.
Use of MAO inhibitors: Should not be used in combination with monoamine oxidase (MAO) inhibitors (can cause a life-threatening crisis).
Pregnancy: Can cause harm to a developing fetus (neural tube defects).
Breastfeeding: Present in breast milk and may cause harm to a nursing infant.

Monitoring: Baseline FBC, BU, SE, LFT, Weight. Repeat in 6 months. Use adequate contraception in women of childbearing age + Folic acid 5mg/daily. Avoid MAOIs.

3. Oxcarbazepine

Structurally related to carbamazepine (it is a prodrug).
Active form: eslicarbazepine.
Mechanism of action is similar to carbamazepine.
Less sedating, less bone marrow toxicity, and less hepatic enzyme inducing than carbamazepine.
Mood stabilizer effects are not definitively proven, but it is used off-label due to better tolerability than carbamazepine (especially for mania).

4. Lamotrigine

Indications: Acute treatment of bipolar depression and prophylaxis for bipolar depression. Used alone, it does not have significant acute or prophylactic anti-manic actions.
Mechanism of Action: Similar to carbamazepine. Blocks VSSC (alpha subunit) and reduces excitatory glutamate neurotransmission.
Adverse Effects: Nausea, headache, diplopia, blurred vision, dizziness, ataxia, tremor.
- Skin Rashes (3%): Usually maculopapular. However, it carries a severe Black Box Warning for life-threatening rashes: Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). Requires very slow dose titration.
- Angioedema.
- Risk of cleft palate in women of childbearing age (low risk).

5. Gabapentin & Pregabalin

Structural analogues of GABA.
Mechanism of action: Inhibition of the alpha-2 delta subunit of voltage-gated Ca++ channels.
Not considered to be effective primary mood stabilizers.
They possess anxiolytic, sedative, and analgesic properties, making them useful as adjunctive treatments to other mood stabilizers to control anxiety or sleep disturbances.

6. Topiramate

Anticonvulsant and antimigraine drug. Not clearly effective as a standalone mood stabilizer.
Mechanism of action: Enhance GABA function and reduce glutamate function by interfering with Na+ and Ca++ channels.
Useful as an adjunctive treatment in bipolar disorder primarily by reducing weight gain, insomnia, and anxiety (often counteracting the weight gain caused by Lithium or Valproate). Cognitive dulling is a common side effect.

VI. Atypical Antipsychotics as Mood Stabilizers

Agents such as Olanzapine, Quetiapine, Risperidone, and Aripiprazole.

Atypical antipsychotics are proven to be highly effective in treating acute mania and preventing the recurrence of mania.
Newer data suggests certain atypicals (e.g., Quetiapine, Lurasidone) are effective in treating bipolar depression and preventing the recurrence of depression.
Proposed Mechanisms:
- 5HT2A antagonism: Reduces glutamate hyperactivity (an action shared by several anticonvulsant mood stabilizers).
- Increasing monoamine neurotransmitters (5HT, NA, DA): Important in improving mood in the depressive phases.

VII. Mood Stabilizer Combinations

The majority of bipolar patients need treatment with several medications. Combining agents allows doses of each agent to be lowered to tolerable levels, and synergy provides greater efficacy than a single agent in high doses.

Widely Used (Safe) Combinations:

Atypical Antipsychotic + Lithium
Atypical Antipsychotic + Valproate
Lithium + Valproate
Lamotrigine + Valproate (Note: Valproate inhibits the metabolism of Lamotrigine, doubling its levels. Lamotrigine dose must be drastically reduced to avoid SJS).
Lamotrigine + Lithium
Lamotrigine + Lithium + Valproate

Dangerous Combinations:

Lithium + Carbamazepine: High risk of severe Neurotoxicity.
Lamotrigine + Carbamazepine: Increased neurotoxicity and unpredictable pharmacokinetic interactions (CBZ induces Lamotrigine metabolism).

NURSING CARE PLAN & RESPONSIBILITIES

Nurse's Responsibilities for Patients Receiving Mood Stabilizers (Focus: Lithium)

No.	Nursing Responsibility / Diagnosis	Interventions & Rationale
1	Pre-Treatment Workup & Assessment	Perform a thorough assessment before starting treatment (Physical exam, history). Ensure baseline labs are drawn: ECG, FBS, Creatinine, Electrolytes, Urinalysis, and TFTs. Rationale: Renal side effects are common; drug is dangerous in compromised kidneys. It also depresses the thyroid gland.
2	Medication Administration & Dosing Adherence	Administer on a regular basis, preferably at the same time daily. Missed Dose Protocol: If a client on a TID schedule forgets a dose, they should wait until the next scheduled time. Never double the dose. Rationale: Doubling the dose easily triggers acute Lithium toxicity due to the narrow therapeutic index.
3	Risk for Imbalanced Fluid Volume (The Sodium Connection)	Massive Clinical Point: Maintain a consistent, adequate sodium and fluid intake (2-3 liters/day). Rationale: If the patient sweats heavily (losing sodium), the kidney reabsorbs Lithium instead of Sodium, leading to rapid, fatal toxicity. Never put a Lithium patient on a low-sodium diet or administer loop/thiazide diuretics without extreme caution.
4	Monitoring for Toxicity & Adverse Effects	Monitor for mild expected side effects (fine tremors, polyuria, thirst, nausea) vs. severe toxic effects (vomiting, extreme hand tremors, sedation, muscle weakness, vertigo, ataxia). If toxic signs appear, hold the medication and notify the psychiatrist immediately. Monitor Lithium blood levels: Draw blood in the morning, approximately 12-14 hours after the last dose.
5	Patient Education & Collaboration	Educate the patient/family on proper dosage, recognizing toxicity signs, and avoiding dehydration. Warn against taking OTC NSAIDs (like Ibuprofen) which can increase Lithium levels. Ensure regular follow-up every 6 months for electrolytes, urea, creatinine, CBC, and TFTs.

References

American Psychiatric Association. (2020). Practice Guideline for the Treatment of Patients With Bipolar Disorder.
Brunton, L. L., Hilal-Dandan, R., & Knollmann, B. C. (2017). Goodman & Gilman's The Pharmacological Basis of Therapeutics (13th ed.). McGraw-Hill Education.
Katzung, B. G. (2017). Basic & Clinical Pharmacology (14th ed.). McGraw-Hill Education.
Sachs, G. S. (1996). Bipolar mood disorder: practical strategies for acute and maintenance phase treatment. Journal of Clinical Psychopharmacology.
Provided Presentation Slides and Lecture Notes on Mood Stabilizers (Source Material).

Quick Quiz

Mood Stabilizers Quiz

Pharmacology - mobile-friendly and focused practice.

Full Name Email Address

Privacy: Your details are used only for quiz tracking and certificates.

Mood Stabilizers Read More »

Organophosphates poisoning

Organophosphate Poisoning Lecture Notes

I. Introduction and Fast Facts

Organophosphates Poisoning is a serious medical emergency that occurs when a person develops an illness as a result of exposure to organophosphates (OPs). Organophosphates are chemicals extensively used in agriculture as insecticides. When humans—particularly agricultural workers—are exposed to large quantities, these chemicals can be severely harmful or fatal.

Other Uses: They are also used as nerve agents in chemical warfare (e.g., Sarin gas, Soman, Tabun, VX) and occasionally as therapeutic agents (e.g., ecothiopate for glaucoma).
Global Impact: There are no rules and regulations governing the purchase of these products in many regions, making them readily available "over the counter." This leads to an estimated 3 million exposures and 300,000 mortalities globally each year.
Exposure Context: Exposure in an attempt to commit suicide is a key problem, particularly in developing countries, and is a more common cause of severe poisoning than the chronic exposure experienced by farmers or sprayers.

Key Definitions

Poison: A foreign chemical that is capable of producing a harmful effect on a biologic system (xenobiotic).
Poisoning: The development of harmful effects on normal body functions following exposure to chemicals after it is swallowed, inhaled, injected, or absorbed cutaneously.

Classification by Toxicity

There are more than a hundred organophosphorus compounds in common use, classified according to their toxicity and clinical use:

Toxicity Level	Common Examples	Primary Use
1. Highly Toxic	Tetra-ethyl pyrophosphates (TEPP), Parathion	Agricultural insecticides
2. Intermediately Toxic	Coumaphos, Chlorpyrifos, Trichlorfon	Animal insecticides, antihelminthic agents
3. Low Toxicity	Diazinon, Malathion, Dichlorvos	Household applications and field sprays

Common Organophosphates include:

Parathion
Fenthion
Malathion
Diazinon
Dursban
Quinalphos
Prothoate

Fast Facts on Organophosphate Poisoning

Nearly 25 million cases of unintentional pesticide poisoning occur in the agricultural industry across the world each year.
Globally, it is reported that 3 million or more people are exposed to OPs every year, accounting for approximately 300,000 mortalities.
In the United States, there are around 8,000 exposures per year, with fewer deaths.
Poisoning leads to significant morbidity and mortality each year in India. According to the National Crime Records Bureau of India, there were 27,657 deaths and suicides by poisoning in 2015.
Cases are most common in regions where workers do not use or do not have access to protective gear, such as specialized suits or masks.
Symptoms and complications vary wildly but can quickly escalate to death.

II. Pathophysiology of Organophosphate Poisoning

Organophosphates exert their acute toxic effects by causing massive overstimulation at cholinergic nerve terminals.

Normal Function: Acetylcholine (ACh) is a vital neurotransmitter found in the central and peripheral nervous systems, neuromuscular junctions, and red blood cells (RBCs). Normally, the enzyme acetylcholinesterase (AChE) catalyzes the rapid degradation of ACh into choline and acetic acid in the nerve synapse, ending the nerve signal.
The Toxic Mechanism: OP pesticides act by binding irreversibly to the AChE enzyme.
The Consequence: This binding severely reduces the ability of the enzyme to break down the neurotransmitter. This produces a massive, uncontrolled accumulation of ACh in the central and peripheral nervous systems.
The Result: This accumulation results in an acute cholinergic syndrome via continuous, unrelenting neurotransmission.

The clinical onset of cholinergic overstimulation can vary from almost instantaneous to several hours after exposure. Although most patients rapidly become symptomatic, the onset and severity of symptoms depend heavily on the specific compound, the amount, the route of exposure, and the rate of metabolic degradation in the patient's body.

Routes of Absorption during OP Poisoning:

Ingestion: Through the Gastrointestinal (GI) tract (can be accidental or deliberate/suicidal).
Cutaneous: Absorption directly through the skin (common in occupational exposure).
Inhalation: Absorption through the lungs.

III. Signs and Symptoms of Organophosphate Poisoning

The length and strength of the exposure will determine the nature of the symptoms, which can range from mild to severe emergency-level toxicity.

A. Symptoms by Severity

1. Mild Exposure:

Blurry or impaired vision, watery/stinging eyes, narrowed pupils
Nausea
Runny nose, extra saliva
Headache
Muscle fatigue, weakness, or minor twitching
Agitation and glassy eyes

2. Moderate Exposure:

Dizziness, disorientation
Very narrow pupils (miosis)
Muscle tremors, pronounced twitching, and weakness
Drooling, excessive phlegm
Wheezing, coughing, and difficulty breathing
Severe vomiting and severe diarrhea
Sneezing and uncontrolled urination or bowel movements

3. Emergency-Level (Severe) Exposure:

Extreme confusion or Coma
Pinpoint narrow pupils
Convulsions / Seizures
Agitation
Massive, excessive secretions (saliva, sweat, tears, mucus)
Irregular or slow heartbeat (bradycardia)
Collapsing
Breathing that becomes ineffective or stops completely (respiratory arrest)

B. Signs and Symptoms according to Receptor Stimulation

The accumulation of acetylcholine overstimulates two main types of receptors: Muscarinic and Nicotinic.

Muscarinic Signs and Symptoms

"Musc leaks from everywhere" - There are excessive secretions from everywhere in muscarinic overstimulation. Remember the mnemonic SLUDGE:

S - Salivation
L - Lacrimation (tears)
U - Urination
D - Defecation
G - GI cramps
E - Emesis (vomiting)

Nicotinic Signs and Symptoms

"Nics give tension, weakness, and paralysis" - Remember the mnemonic MT WTF:

M - Mydriasis (Note: while miosis is the classic muscarinic sign, sympathetic override can occasionally cause mydriasis)
T - Tachycardia
W - Muscle Weakness
T - Muscle Twitching
F - Muscle Fasciculation
BP is high - Hypertension
Paralysis is happening - Muscle paralysis

C. Long-Term Complications

In addition to immediate symptoms, OP exposure can cause long-term complications depending on the extent of exposure:

Paralysis
Fertility issues
Cancer
Metabolic disorders (e.g., high blood sugar levels)
Inflammation of the pancreas (Pancreatitis)
Excess acid in the blood (Acidosis)
Brain and nerve problems (Organophosphate-induced delayed polyneuropathy - OPIDN)

IV. Diagnosis of Organophosphate Poisoning

History: Determine the type of exposure (occupational, accidental, deliberate ingestion), time of exposure, and specific chemical if known.
Physical Examination: Look for classic signs (SLUDGE, miosis, garlic-like odor on breath).
Vital Signs: Depressed respirations, bradycardia, and hypotension are common, life-threatening findings.
Laboratory Investigations:
- Plasma pseudocholinesterase levels: Normal is 3000–8000 U/L. In poisoning, serum levels may drop to < 1000 U/L.
- RBC AChE level: A more accurate marker of nervous system AChE inhibition.
- White blood cells (WBC): Leucocytosis is frequently seen.
- ABG values: To rule out or confirm metabolic and/or respiratory acidosis.
- Electrolytes: Potassium and magnesium levels are often decreased.
Imaging Studies:
- Chest X-ray for aspiration pneumonia or pulmonary edema.
- Electrocardiogram (ECG) for ventricular arrhythmias, prolonged QTc, or heart block.

V. Medical Management of Organophosphate Poisoning

Step I: Identification

Identify the specific nature of the poison (e.g., OP, carbamate, chloride, pyrethroid) to guide specific antidote therapy.

Step II: Decontamination & Safety

Staff Safety: Staff must put on protective equipment before commencing treatment, including masks, gowns, eye protection, and specialized gloves (usually nitrile/rubber, as OPs penetrate latex). Staff involved in direct contact with the patient’s bodily secretions should immediately and thoroughly wash affected areas with soap and water.
Physical Decontamination: Remove all clothing. Wash the patient thoroughly with soap and copious amounts of water.
Gastric Decontamination: Gastric lavage should be done only after stabilizing the airway. It is generally given within 1 hour of ingestion. Activated charcoal (0.5–1 g/kg) can be given within 1 hour of ingestion to bind remaining poison in the gut, though some studies show limited benefit. Do not induce emesis.

Step III: Maintaining Airway, Breathing, and Circulation (ABC)

Airway: Maintain a clear airway via frequent suctioning of excessive secretions. Check the gag reflex. If absent, intubate before any stomach wash is performed to prevent aspiration.
Breathing: Administer oxygen at 6 L/min. Intubation and mechanical ventilation are required if breathing is inadequate, oximetry is <90%, or the Glasgow Coma Scale (GCS) is <8.
Circulation: Administer adequate intravenous (IV) fluids through a wide bore cannula to replace volume loss from severe vomiting and diarrhea.

Step IV: Cardiac Monitoring

Continuously monitor for fatal arrhythmias (e.g., ventricular tachycardia, Torsades de pointes) using an ECG.

Step V: Specific Therapy & Antidotes

1. Atropine (To reverse Muscarinic effects)

Protocol for Atropinisation: Atropinisation must be initiated as soon as the diagnosis is suspected. The aim is to keep the patient's airway dry. Administer Injection Atropine 2 mg IV bolus (or 0.05 mg/kg). The dose is then doubled every 5 minutes until adequate atropinisation is achieved.
Signs of Atropinisation (Target End-Points):
- Heart rate about 100/min
- Pupils return to mid-position
- Bowel sounds just heard (not hyperactive)
- Clear lung sounds (secretions dry up)
- Dry skin
Signs of Atropine Toxicity (Anticholinergic Toxidrome): Care must be taken not to over-atropinise. Signs include: Dry mucus membranes ("dry as a bone"), mental status changes/delirium ("mad as a hatter"), flushed skin ("red as a beet"), severe mydriasis ("blind as a bat"), fever ("hot as hell"), severe tachycardia, hypertension, decreased bowel sounds, and urinary retention.
Treatment for Toxicity: Atropine toxicity is treated with injection haloperidol (5 mg IM or IV) for agitation, and by immediately reducing or pausing the dose of atropine.

2. Supportive Medications

Oximes (e.g., Pralidoxime/PAM): Given to reactivate the AChE enzyme and reverse nicotinic effects (muscle weakness/paralysis). Must be given early before the enzyme "ages."
Antibiotics: Not usually indicated for OP poisoning itself. However, gastric lavage with an unprotected airway and/or a low GCS creates a massive risk for aspiration. If aspiration pneumonia is suspected (fever, leucocytosis, pulmonary infiltrates), broad-spectrum antibiotics (e.g., Ceftriaxone, Piperacillin/Tazobactam [Piptaz]) are indicated.
Sedation: Agitation may indicate over-atropinisation, hypoxaemia, or distress. Intubated patients need a combination of an analgesic and a sedative (e.g., morphine + lorazepam infusion). Haloperidol may increase the seizure threshold and is not recommended unless patients are unresponsive to other drugs.
Diuretics: Lasix (Furosemide) is the drug of choice if pulmonary edema persists even after full atropinisation has been achieved.

NURSES ROLES DURING MANAGEMENT OF OP POISONING

No.	Nursing Responsibility	Clinical Rationale
A. Airway & Respiratory Management
1	Assess the airway for bilateral equal air entry, respiratory rate, and breath sounds. Check for bronchospasms.	Respiratory failure is the primary cause of death; continuous assessment is vital.
2	Position the patient in semi-Fowler’s at 45° and change position every 2 hours.	Promotes diaphragmatic descent, maximal lung expansion, mobilizes secretions, and actively prevents aspiration of vomit.
3	Perform frequent, aggressive airway suctioning whenever necessary.	Bronchorrhea (massive lung secretions) can rapidly occlude the airway.
4	Assess for cough and gag reflex; assist immediately with intubation if absent.	An absent gag reflex means the patient cannot protect their airway from massive secretions or vomit.
5	Provide humidification to airways and check ventilator settings closely if mechanically ventilated.	Thins out thick secretions and ensures optimal mechanical oxygenation.
B. Hemodynamic & Systemic Monitoring
6	Assess heart rate, rhythm (via ECG) for arrhythmias, BP, capillary refill time, skin turgor, and vital signs every hour.	OP poisoning and Atropine therapy both cause massive, rapidly shifting hemodynamic instability.
7	Administer IV fluids and Atropine infusions accurately as prescribed.	Fluids combat hypovolemia from GI losses; Atropine must be titrated meticulously to maintain the heart rate above 90/min without causing severe toxicity.
8	Monitor urine output every hour via a Foley catheter.	Assesses renal perfusion and checks for urinary retention (a sign of atropine toxicity).
9	Check for neck muscle weakness and the use of accessory muscles for breathing. Assess "single breath count."	These are critical early warning signs of impending nicotinic respiratory muscle paralysis.
C. Infection Control & Supportive Care
10	Follow strict aseptic technique while handling invasive lines and performing suctioning.	Prevents secondary healthcare-associated infections in a critically ill patient.
11	Provide rigorous oral care with chlorhexidine solution.	Prevents Ventilator-Associated Pneumonia (VAP) and manages excessive oral secretions.
12	Administer prophylactic or therapeutic antibiotics (e.g., Injection Piptaz 4.5 g IV q 8 hourly) as per order.	Treats suspected or confirmed aspiration pneumonia.
13	Monitor ABG values, WBC counts, culture and sensitivity results, and chest X-rays.	Provides objective data on respiratory acidosis, infection status, and pulmonary edema.
14	Evaluate the patient's feelings and perception of their lack of power; involve them in care when conscious.	Addresses the severe psychological trauma of a suicide attempt or a terrifying accidental poisoning, promoting mental recovery.

Nurses roles during management of organophosphate poisoning

Assessing the airway for bilateral equal air entry, respiratory rate and breath sounds
Assessing for cough and gag reflex and for bronchospasms.
Changed position every 2 hourly to mobilize secretions.
Positioning him in semi-fowlers at 45° to promote lung expansion and to prevent aspiration.
Maintaining adequate hydration by administering IV fluids.
Providing humidification to airways to thin secretions.
Checking for neck muscle weakness, use of accessory muscles for breathing.
Assessing single breath count.
Assisting for intubation.
Checking the ventilator settings of the patient.
Positioning patient in semi-fowler’s position to promote diaphragmatic descent and maximal inhalation.
Performing suctioning whenever necessary.
Assessing heart rate, rhythm for arrhythmias, BP, capillary refill time, skin turgor, vital signs every hour.
Assessing peripheral sites for perfusion.
Monitoring urine output every hour.
Administered atropine infusion to maintain the heart rate above 90/min.
Monitoring vital signs.
Following strict aseptic technique while handling invasive lines and while performing suctioning.
Providing oral care with chlorhexidine solution.
Checking for the colour, consistency and volume of secretions.
Monitored ABG values, WBC counts, culture and sensitivity results, chest X-ray.
Administering injection Piptaz 4.5 g IV q 8 hourly as per the order.
Evaluating his feelings and perception of the reasons for lack of power and sense of helplessness.
Involving him in care.
Identifying his usual belief/locus of control that influences his life

Quick Quiz

Organophosphate Poisoning Quiz

Pharmacology - mobile-friendly and focused practice.

Full Name Email Address

Privacy: Your details are used only for quiz tracking and certificates.

Organophosphates poisoning Read More »

Storage Of Narcotics

Storage, Dispensing, and Legal Implications of Narcotics

Narcotics (Class A / Schedule II controlled drugs) are highly regulated pharmacological agents associated with addiction, tolerance, and a high potential for abuse. Because of these risks, governments and healthcare institutions must enforce strict prevention protocols, ensuring these medications are properly stored in such a way that limits access strictly to authorized personnel.

I. Storage and Dispensing of Narcotics

The following are the specific responsibilities and protocols in regard to the storage of narcotics across different hospital departments.

A. Storage in the Pharmacy

Secure Location: The drugs must be kept in a separate, dedicated locked cupboard.
Key Management: The key to the narcotic cupboard must be handled exclusively by the registered pharmacist.
Documentation: A dedicated register book must be kept up-to-date, indicating the total quantity of each drug, the date of transaction, and the required signatures.
Dispensing Protocol: During the issuing of drugs, the FEFO Method (First Expiry, First Out) must be strictly utilized to prevent drug expiration on the shelves.
Record Retention: The narcotic register book must be kept securely for a minimum of 2 years from the date of the last entry.

B. Storage on the Ward

Double-Lock System: All narcotics must be stored in a double-locked compartment or an automated dispensing cabinet (with the exception of refrigerated narcotic infusion bags, which have specific secure protocols).
Key Management: The keys for the locked compartment/cupboard must be carried on the person of the nursing unit personnel (especially the Ward In-Charge) or stored in an approved lock-box at all times. A spare key must be kept with the pharmacist.
Shift Handovers: In areas with more than one narcotic key, staff must account for all keys at the end of each shift and document this in the Narcotic Controlled Drug (NCD) administration record books.
Organization: Ampoules must be clearly labeled and physically separated by drug type and dosage to prevent medication errors.
Lost Keys: Keys that are lost or removed from the hospital premises require an immediate lock/key replacement by physical plant personnel.
Ward Register: There must be a dedicated register book for stock-in and stock-out on the ward.
Ampoule Retention: Empty ampoules must be kept and returned to the pharmacy for replacement validation.
Stock Rotation & Records: Use the FEFO method and keep all ward narcotic records for two years.

Narcotic Documentation and Discrepancy Management on the Ward:

All narcotics received and issued out on nursing units must be documented in the NCD administration record book or within the automated dispensing system's electronic record. Issues must explicitly include the patient's name, the physician's name, and the exact dose.
Wastage: All wastage of NCDs must be signed by a witness after directly observing the wastage being disposed of into the sharps container on the unit.
Shift Counts: Narcotic counts must be performed once per shift by two nurses. An incident report must be completed for any discrepancies not resolved prior to the shift change.
Variances: A count variance of less than 5% for oral narcotic solutions can be corrected without the completion of an incident report.
Management Oversight: The Patient Services Manager is responsible for ensuring discrepancies are resolved and that all required signatures are obtained in the NCD administration book, which must be returned to the pharmacy within 2 weeks of completion.

II. Key Considerations in Narcotic Storage

The responsibility for the storage of narcotics typically falls on the Pharmacy staff, while on the wards, storage falls on the nursing staff. They must ensure that the drugs are stored in a secure and controlled environment and that access is restricted only to authorized personnel. Nurses must be intimately aware of the regulations and guidelines governing the storage and handling of narcotics, strictly following protocols to prevent diversion, abuse, and misuse.

1. Secure Storage:

Narcotics must be stored in a secure and locked cabinet or safe, accessible only to authorized personnel. For ward storage, the storage area should be located in a secure, well-lit area away from public access, preferably near the nursing station for continuous, easy monitoring.

2. Proper Labeling:

All narcotics must be labeled with their generic name, strength, quantity, lot number, and expiration date. The labels must be highly legible and firmly affixed to the container. Any outdated or damaged labels must be replaced immediately.

3. Accurate Inventory:

An accurate inventory of all narcotics must be maintained at all times, with regular checks and reconciliations between the actual physical stock and the recorded inventory. The nursing staff must meticulously document any discrepancies, losses, or incidents related to the use or storage of narcotics.

4. Temperature Control:

Certain narcotics, such as fentanyl and hydromorphone, are particularly sensitive to temperature and humidity. They must be stored in a cool and dry environment to prevent degradation or loss of potency. The storage area must be monitored regularly for temperature and humidity levels, and any deviations from the recommended range must be promptly reported and addressed.

5. Access Control:

Access to the narcotics storage area must be strictly controlled and limited to authorized personnel who have been trained and approved to handle and administer narcotics. The nursing staff must follow strict protocols for accessing and dispensing narcotics, including checking the patient’s identity, verifying the prescription and dosage, and documenting the administration.

6. Disposal:

Narcotics that are expired, damaged, or no longer needed must be disposed of properly, in strict accordance with government regulations. The nursing staff must follow the legally prescribed procedures for disposing of narcotics.

III. Expired, Rejected, or Returned Class A Drugs

Unused drugs must be returned directly to the prescriber or dispenser.
If a narcotic is expired or rejected for any reason, it must be returned to the pharmacy In-Charge, who will then contact the national Drug Inspector.
Expired drugs should be destroyed by the pharmacy In-Charge ONLY when witnessed by the Drug Inspector.
Destruction must follow the World Health Organization (WHO) guidelines for the disposal of controlled substances.
The precise details of the quantity destroyed and the reason for destruction must be written in the Class A register.

IV. Importation of Class A Drugs

The manufacture and wholesale of Class A drugs require an annual import license.
Currently, the National Drug Authority (NDA) allows only the National Medical Stores (NMS - Government) and the Joint Medical Stores (JMS - NGO) to import narcotics directly.
Private retail pharmacies and private hospitals must access their narcotic stock through the above-authorized agencies.

V. Prescription Practices and Ordering

Prescribing narcotics is the process of sending a highly regulated written document from a licensed prescriber to the dispenser ordering specific controlled substances.

A. Ordering and Dispensing Workflow

Ordering in the Pharmacy to the Wards:

In the pharmacy, the responsible person obtains the drugs from the registered body. As far as ordering is concerned, the pharmacist keeps absolute records of all entries of drugs.
Narcotics must be dispensed by a registered pharmacist or authorized medical practitioner.

Ordering on the Ward:

Being a group of drugs that can easily be abused, the prescription of narcotics on the ward has been limited to registered medical practitioners (doctors) who should prescribe them only after evaluating that other NSAIDs cannot relieve the pain (e.g., severe post-surgical pain, cancer treatment, palliative care).
The doctor must make 2 copies of the prescription: one is retained in the stores/pharmacy, and the other is kept in the patient's clinical file.
The order has to be written clearly with the full names of the prescriber and their signature, the drug name, the patient's name, route of administration, and duration of therapy.
If the Ward In-Charge orders the drug for unit stock, he or she must sign the orders properly.
On collection from the pharmacy, the drugs must be cross-checked.
After checking, the nurse who receives the drugs signs for them to confirm receipt and assumes custody.
The drug given to a patient must subsequently be accounted for by handing over the empty ampoules.

B. Prescription Requirements

Prescription forms for Class A drugs must contain all required details because they are binding legal documents.

Allowed Prescribers for Class A Drugs:

Registered Medical Doctor
Registered Dentist
Registered Veterinary Surgeon
Specialized Palliative Care Nurse or Clinical Officer

Validity and Limitations:

The prescription is valid for 14 days from the date of issue.
The total supply prescribed must not exceed 1 month.
The prescription must be written in duplicate.

Mandatory Inclusions on the Prescription:

Patient's full name, age, sex, and address.
Total dose of drugs prescribed written in both words and figures.
Stipulated form of the drug (e.g., tablets, oral solution, injection).
Specific strength where possible (e.g., 5mg/5mls or 50mg/5mls oral morphine).

VI. Administration of Narcotics on the Ward

The drug to be administered must be explicitly prescribed by the doctor.
The drug must be administered by a qualified nursing staff member or a 3rd-year nursing student under the direct supervision of a qualified staff member.
Both individuals (the administrator and the witness/supervisor) must sign in the narcotic register immediately after administration.
The drug must be administered strictly according to the Five Rights (5 R's) of Medication Administration: Right patient, Right drug, Right dose, Right route, Right time.
Empty ampoules must be physically handed over to the Ward In-Charge.
In case of any remainder (partial dose used), the remaining drug should be taken back to the pharmacy or wasted according to protocol.
Any drug wasted must be recorded and signed for by a witness.

VII. Precautions on Narcotics

Must only be dispensed by a registered pharmacist or medical practitioner.
Medical practitioners are strictly prohibited from obtaining or prescribing the drug for personal use.
Always keep the drug in proximity with its antidote (e.g., Naloxone/Narcan) in case of an overdose or respiratory depression.
The order must be from a doctor/medical practitioner using a legally prescribed form.
Transportation must be legal (should be transported securely by legal means between facilities).
Facilities must fully comply with all rules from the National Drug Authority (NDA).
The Health Inspector must be allowed to check on records and obtain samples at any given time.
Individuals and private entities are not allowed to export or import narcotics. Trade is strictly restricted to licensed pharmacists and authorized drug shops/agencies.

VIII. Legal Implications and Penalties

Narcotic drugs are highly controlled under the law. In Uganda, the legal framework is primarily guided by the National Drug Policy and Authority (NDA) Act and the rigorous Narcotic Drugs and Psychotropic Substances (Control) Act (formerly Act No. 3 of 2016, recently revised/consolidated as the 2024 Act).

A. Regulatory and Institutional Framework

The National Drug Authority (NDA): Establishes the regulatory framework for the importation, exportation, and distribution of controlled substances. The Authority has the power to issue licenses and permits for the manufacture, distribution, and sale of narcotics, and to conduct unannounced inspections to ensure compliance with the Act's provisions. (Note: The NDA statute undergoes periodic review, and guidelines for handling Class A drugs established in 2001 work in tandem with the Pharmacists’ Council).
Treatment and Rehabilitation: The Act creates a legal framework for the treatment and rehabilitation of individuals with substance use disorders. It mandates the establishment of a National Drug Policy and a National Drug Abuse Prevention and Control Program designed to prevent drug abuse, promote public awareness, and rehabilitate struggling individuals under the guidance of the Uganda Mental Health Advisory Board.

B. Criminal Offenses and Severe Penalties

The Act heavily criminalizes the unlawful possession, sale, manufacture, and trafficking of narcotics (including cocaine, heroin, cannabis, etc.). Those found guilty face exceptionally severe penalties, which may include lengthy imprisonment, exorbitant fines, and total forfeiture of property.

Offense	Description	Legal Penalty (per NDPS Act Guidelines)
Unlawful Possession	Possession of narcotic drugs or psychotropic substances without lawful medical/pharmacological authority.	A fine not exceeding 50,000 currency points (approx. 1 Billion UGX) or three times the market value of the drug (whichever is greater), OR imprisonment not exceeding 20 years, or both.
Trafficking	Importation, exportation, manufacture, buying, selling, or distributing narcotics without a license.	A fine not exceeding 50,000 currency points or three times the market value (whichever is greater), OR Life Imprisonment, or both.
Malicious Entry / Seizure	A police officer or authorized person executing a search/seizure without reasonable grounds of suspicion.	A fine not exceeding 24 currency points or imprisonment not exceeding 10 years, or both.
Supply to a Child	Knowingly supplying a narcotic to a child when it is not required for medical treatment.	A fine not exceeding 50,000 currency points or Life Imprisonment, or both.
General Misconduct	Failure to comply with regulations, poor record-keeping, or general unlawful possession of classified drugs.	Historically applied fines not exceeding 2 million UGX or imprisonment for a term not exceeding 2 years, up to the maximums defined by specific schedules.

Important Exemption: Penalties for possession do not apply to a licensed medical practitioner, dentist, veterinary surgeon, registered pharmacist, clinical officer, or specialized palliative care nurse who is in possession of a narcotic drug strictly for a legitimate medical purpose or under a valid NDA license.

Overall, it is critical for healthcare professionals to understand the profound legal implications of narcotics and to comply meticulously with the provisions of these Acts. Proper storage, dispensing, and administration records protect the nurse and the facility from facing these serious legal consequences.

IX. References

The Narcotic Drugs and Psychotropic Substances (Control) Act, Uganda (Consolidated 2024 / Act No. 3 of 2016).
The National Drug Policy and Authority (NDA) Act and 2001 Guidelines for Handling Class A Drugs, Uganda.
World Health Organization (WHO) Guidelines for the Safe Disposal of Unwanted Pharmaceuticals in and after Emergencies.
Standard Operating Procedures for Narcotic Storage and Dispensing in Clinical Settings.

Quick Quiz

Narcotic Storage Quiz

Pharmacology - mobile-friendly and focused practice.

Full Name Email Address

Privacy: Your details are used only for quiz tracking and certificates.

Storage Of Narcotics Read More »

Anxiolytic and Hypnotic Agents

Sedative, Hypnotic, and Anxiolytic Drugs

Anxiolytic agents are drugs used to depress the central nervous system (CNS) to prevent the signs and symptoms of anxiety. Hypnotic agents are drugs used to depress the CNS to cause sleep. In general, these drugs will induce sleep when given in high doses at night and will provide sedation and reduce anxiety when given in low divided doses during the day.

I. Common Terms and Definitions

Anxiety: An unpleasant feeling of tension, fear, apprehension, or nervousness in response to an environmental stimulus, whether real or imaginary. The physical symptoms of severe anxiety are similar to those of fear (tachycardia, sweating, trembling, palpitations) and involve sympathetic activation.
Sedative: A drug that depresses the CNS; produces a calming effect, reduces excitement, and produces a loss of awareness of and reaction to the environment. It may induce drowsiness without necessarily inducing sleep.
Sedation: The loss of awareness of and reaction to environmental stimuli.
Hypnotic: A drug that induces sleep resembling natural sleep. Both sedation and hypnosis may be considered as different grades of CNS depression.
Hypnosis: Extreme sedation resulting in CNS depression and sleep.
Benzodiazepine: A class of drugs that acts in the limbic system and the reticular activating system to make gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter, more effective, causing interference with neuron firing; depresses CNS to block the signs and symptoms of anxiety, and may cause sedation and hypnosis in higher doses.
Barbiturate: A former mainstay drug class used for the treatment of anxiety and for sedation and sleep induction; associated with potentially severe adverse effects and many drug–drug interactions, which makes it less desirable than some of the newer agents.

II. Physiology of Sleep and Sleep Disorders

Sleep is a naturally periodic state of mind and body, characterized by altered consciousness. It is vital for heart health, reducing stress and inflammation, improving memory, weight loss, and maximizing athletic and intellectual performance.

A. The Sleep Cycle

A normal sleep cycle consists of non-rapid eye movement (NREM) and rapid eye movement (REM) sleep.

NREM Sleep (Non-Rapid Eye Movement): Comprises four stages.
- Stage 1 (Lightest, 1-7 min): Heartbeat and breathing slow down, muscles relax with occasional twitches, brain waves begin to slow.
- Stage 2 (Light, 10-25 min): Heartbeat and breathing slow further, body temperature drops, eye movements stop.
- Stage 3 (Deep sleep, 20-40 min): Heartbeat and breathing reach lowest levels, muscles stay relaxed.
- Stage 4 (Deepest NREM): Profound CNS depression; restorative sleep.
REM Sleep (20-40 min): Eyes move rapidly from side to side behind closed eyelids. Breathing speeds up and becomes irregular, heart rate and blood pressure increase. Dreams typically happen during REM sleep.

B. Common Sleep Disorders

Insomnia: A sleep disorder in which you have trouble falling and/or staying asleep. Acute insomnia lasts from 1 night to a few weeks. Chronic insomnia happens at least 3 nights a week for 3 months or more.
Hyposomnia: Decreased sleep duration.
Parasomnia: Abnormal behaviors during sleep (e.g., Sleep Terrors, Sleep Walking).
Sleep Apnea: Breathing repeatedly stops and starts during sleep.
Narcolepsy: Overwhelming daytime drowsiness and sudden attacks of sleep.
Other disorders: Restless leg syndrome, Bruxism (teeth grinding), REM sleep behavior disorder.

III. Classification of Sedative-Hypnotics

Benzodiazepines (BDZs)	Barbiturates	Newer Non-BDZ Hypnotics / Others
Long-acting: Diazepam, Flurazepam, Clonazepam, Prazepam, Chlordiazepoxide, Quazepam	Long-acting: Phenobarbital, Mephobarbital, Metharbital	Z-Drugs (Non-BDZ Hypnotics): Zolpidem, Zaleplon, Eszopiclone Anxiolytics: Buspirone, Meprobamate Others: Chloral hydrate, Promethazine, Diphenhydramine, Dexmedetomidine, Ramelteon
Intermediate-acting: Nitrazepam, Lorazepam, Oxazepam, Temazepam, Medazepam, Alprazolam, Estazolam	Intermediate-acting: Amobarbital, Apobarbital, Butabarbital
Short-acting: Triazolam, Midazolam	Short-acting: Pentobarbital, Secobarbital Ultra short-acting: Methohexital, Thiopental, Thiamylal

IV. Benzodiazepines (Used as Anxiolytics and Hypnotics)

Benzodiazepines (BDZs) are the most frequently used anxiolytic drugs. They prevent anxiety without causing much associated sedation. In addition, they are less likely to cause physical dependence than many of the older sedatives/hypnotics (like barbiturates) that are used to relieve anxiety.

A. Mechanism of Action (Pharmacodynamics)

GABA is the most potent inhibitory neurotransmitter in the CNS and controls the state of neuronal excitability.
BDZs act by potentiating the action of the neurotransmitter GABA (gamma-aminobutyric acid).
They bind selectively to specific subunits of the GABA-A receptors, at a site distinct from where GABA or barbiturates bind, designated as the benzodiazepine binding site.
Key Feature: Binding of BDZs enhances GABA binding and increases the frequency of chloride channel openings.
This increases the chloride ion concentration inside the neuron, causing hyperpolarization of the neuronal membrane, making it more difficult for excitatory neurotransmitters to depolarize the cell.
The primary sites of action appear to be the limbic system (governing emotions) and the reticular activating system (RAS) (which maintains consciousness, sleep, and alertness).

B. Pharmacological Actions

Antianxiety Effect: They exert a specific effect on the limbic system, reducing anxiety and producing a calming effect. Alprazolam has additional antidepressant properties.
Sedative-Hypnotic Effect: In smaller doses, they cause sedation. In higher doses, they induce sleep (hypnosis). They shorten the time spent in Stage 4 NREM and REM sleep but increase total sleep time. Sleep produced is refreshing with fewer hangover symptoms compared to barbiturates.
Anticonvulsant Effect: Long-acting BDZs (Clonazepam) raise the seizure threshold by potentiating GABA. Lorazepam and Diazepam prevent the spread of seizures in the brain.
Skeletal Muscle Relaxant: Produce relaxation by facilitating GABAergic transmission in the brainstem and spinal cord. Used in acute spasms caused by trauma or upper motor neuron disorders.
Amnesia: BDZs produce anterograde amnesia (loss of memory for events happening after administration). This is highly advantageous during unpleasant surgical or endoscopic procedures.

C. Pharmacokinetics

Absorption: Well absorbed from the gastrointestinal (GI) tract, with peak levels achieved in 30 minutes to 2 hours.
Distribution: Highly lipid-soluble; widely distributed throughout the body. They easily cross the blood-brain barrier, cross the placenta, and enter breast milk.
Metabolism: Metabolized extensively in the liver. Patients with liver disease must receive a smaller dose and be monitored closely.
Excretion: Primarily excreted through the urine.

D. Indications

Anxiety Disorders: Panic disorder, generalized anxiety disorder (GAD), social anxiety disorder, performance anxiety, PTSD, OCD, and extreme phobias.
Sleep Disorders: Used as hypnotic agents for the short-term treatment of insomnia.
Seizures: Status epilepticus (IV Diazepam or Lorazepam), and in the treatment of alcohol withdrawal to reduce the risk of withdrawal-related seizures (Chlordiazepoxide, Diazepam).
Muscular Disorders: Skeletal muscle spasms, degenerative disorders like multiple sclerosis and cerebral palsy.
Preanesthetic / Amnesia: Preoperative relief of anxiety and tension to aid in balanced anesthesia (Midazolam given IM or IV).

E. Contraindications and Cautions

Allergy to any benzodiazepine.
Psychosis: Could be exacerbated by sedation.
Acute conditions: Acute narrow-angle glaucoma, shock, coma, or acute alcoholic intoxication (could be lethally exacerbated by CNS depressant effects).
Pregnancy: Strictly contraindicated. A predictable syndrome of cleft lip/palate, inguinal hernia, cardiac defects, microcephaly, or pyloric stenosis occurs when taken in the first trimester. Neonatal withdrawal syndrome or "floppy infant syndrome" may also result.
Lactation: Contraindicated because of potential adverse effects on the neonate (e.g., severe sedation).
Elderly or Debilitated Patients: Use with extreme caution because of the possibility of unpredictable reactions (paradoxical agitation), delayed metabolism leading to accumulation, and increased fall risk. Dose adjustments are required.
Renal or Hepatic Dysfunction: Alters metabolism and excretion, resulting in direct toxicity.

F. Adverse Effects

CNS Effects: Sedation, drowsiness, depression, lethargy, blurred vision, headaches, apathy, light-headedness, confusion, disorientation, agitation, slurred speech, vertigo, hallucinations, and tremors.
GI System: Dry mouth, constipation, anorexia, nausea, vomiting, and elevated liver enzymes.
Cardiovascular System: Hypotension (especially with rapid IV push), bradycardia, palpitations.
Hematologic: Blood dyscrasias, agranulocytosis, neutropenia, anemia.
Genitourinary (GU): Urinary retention, incontinence, hesitancy, loss of libido, and changes in sexual functioning.
Tolerance and Dependence: While present, liability is significantly less than with barbiturates. Abrupt cessation may lead to withdrawal syndrome (nausea, headache, vertigo, malaise, nightmares, and potentially seizures).

G. Drug Interactions & Antidote

The risk of CNS depression increases significantly if taken with alcohol, barbiturates, opioids, or other CNS depressants. Avoid combinations.
Effects of BDZs increase (due to inhibited metabolism) if taken with cimetidine, oral contraceptives, or disulfiram.
Impact may be decreased if given with theophyllines or ranitidine.
Antidote: Flumazenil (0.1 mg/ml). A competitive benzodiazepine receptor antagonist used for the treatment of overdose.

V. Barbiturates (Used as Anxiolytic-Hypnotics)

The barbiturates were once the sedative/hypnotic drugs of choice. However, the likelihood of profound sedation, severe adverse effects, lack of a specific antidote, a narrow therapeutic index, and the high risk of addiction/dependence has caused them to be largely replaced by newer anxiolytic drugs (BDZs).

A. Mechanism of Action

Barbiturates depress the sensory and motor activity in the cerebral cortex.
They act on the reticular activating system (RAS), elevating the firing threshold and depressing the firing rate of neurons.
They bind selectively to subunits of the GABA-A receptors, at a site distinct from the GABA or BDZ binding site (designated as the Barbiturate binding site).
Key Feature: Barbiturates potentiate GABA action by prolonging the duration of the chloride channel openings. (At high doses, they can directly open the channel even without GABA).
This causes profound hyperpolarization of the neuronal membrane and deep CNS depression.

B. Pharmacological Actions

Sedation: In low doses, they show drowsiness, calmness, and a sense of well-being (euphoria). Due to depression of the RAS.
Hypnosis: Induce sleep in a dose 3 to 4 times higher than the sedative dose. They relieve insomnia by inducing stage 2 of NREM sleep (but suppress REM sleep).
General Anesthesia: Ultra-short acting barbiturates (Methohexital, Thiopental) are administered IV for the rapid induction of general anesthesia. They produce reversible loss of consciousness.
Anticonvulsant Action: Long-acting barbiturates (Phenobarbital, Mephobarbital) block excess neuronal firing. Indicated in grand mal epilepsy and cortical focal seizures.
Respiratory Depression: In large doses, they depress the respiratory center in the medulla oblongata, leading to hypoventilation or fatal apnea.
Enzyme Induction: Barbiturates (especially Phenobarbital) powerfully stimulate the functioning of hepatic microsomal enzymes (CYP450 system). This increases the metabolism and decreases the effectiveness of many concomitant drugs.

C. Pharmacokinetics

Absorbed well, reaching peak levels in 20 to 60 minutes.
Metabolized heavily in the liver.
Excreted in the urine. The longer-acting barbiturates (e.g., Phenobarbital) tend to be metabolized slower and excreted to a greater degree unchanged in the urine (making alkalinization of urine an effective treatment for overdose).

D. Contraindications

Allergy to any barbiturate.
Addiction: Previous history of addiction to sedative/hypnotic drugs (barbiturates are highly addictive).
Porphyria: Strictly contraindicated; barbiturates induce enzymes that synthesize porphyrins, which can trigger a severe, life-threatening acute porphyria attack.
Hepatic impairment or nephritis: Alters metabolism and excretion, leading to rapid toxicity.
Severe respiratory dysfunction: Conditions like COPD or severe asthma could be lethally exacerbated by the respiratory depression.
Pregnancy: Contraindicated because of potential adverse effects on the fetus (depression of fetal respiration during labor) and reported congenital abnormalities.

E. Adverse Effects

Hangover: Due to residual depression of the CNS. Accompanied by headache, nausea, vomiting, vertigo, diarrhea, distortions of mood, and impaired judgment.
Drug Automatism (Memory Loss): When used as a hypnotic, confusion and amnesia may cause a patient to forget they took the pill, repeatedly take more doses at night, and accidentally poison themselves.
Tolerance & Dependence: Repeated administration quickly causes tolerance to sedative/hypnotic actions (but NOT to the lethal respiratory depression threshold). High risk of physical and psychological dependence.
Allergic Reactions: Urticaria, angioneurotic edema, agranulocytosis, thrombocytopenic purpura, serum sickness, and potentially fatal Stevens-Johnson syndrome.
GI Effects: Nausea, vomiting, epigastric pain.
CVS Effects: Bradycardia, hypotension (particularly with IV administration), and syncope.

F. Drug Interactions

Profound, synergistic CNS depression if taken with alcohol, antihistamines, or other tranquilizers.
Altered response to phenytoin when combined with barbiturates.
MAO Inhibitors increase serum levels and effects of barbiturates.
Enzyme Induction: Barbiturates accelerate the metabolism of oral anticoagulants (Warfarin), digoxin, TCAs, corticosteroids, oral contraceptives, estrogens, acetaminophen, metronidazole, beta-blockers, griseofulvin, theophyllines, and doxycycline, severely reducing their clinical effectiveness.

G. Acute Barbiturate Poisoning and Management

Often caused by suicidal attempts or drug automatism. Symptoms include deep CNS depression, respiratory depression, peripheral circulatory collapse, wheezing, hypotension, hypopyrexia, absent reflexes, coma, and potentially death. Fatal complications include atelectasis, pulmonary edema, and pneumonia.

Management Protocol:

Hospitalization & Intensive Care: Immediate admission.
Adequate Tissue Oxygenation: Endotracheal intubation is performed when spontaneous respiration is inadequate and to prevent aspiration/remove secretions. If assisted ventilation is required >24 hours, tracheostomy may be performed.
Gastric Lavage: If the patient is conscious and < 4 hours have elapsed since ingestion, induce vomiting or use lavage. In comatose patients, endotracheal intubation must precede gastric lavage to prevent aspiration pneumonia.
Intravenous Fluids: Given in sufficient quantity to prevent dehydration, maintain blood volume, and support diuresis. Vasopressors (dopamine) used if hypotension persists.
Alkalinisation of the Urine: Sodium bicarbonate (50ml of 7.5% solution) is added to IV fluids. Maintaining urinary pH between 7.5 and 8.5 ionizes the barbiturate (a weak acid) in the urine, preventing reabsorption and drastically increasing the excretion of long-acting agents like phenobarbital.
Forced Diuresis: Osmotic diuretics (Mannitol 25%) or loop diuretics (Furosemide 20 mg) are administered to aggressively flush the drug through the kidneys.
Hemodialysis: About 40 times more effective than forced diuresis in promoting elimination. Highly indicated in severe cardiac/renal impairment where massive fluid loading is contraindicated.
Prophylactic Antibiotics: May be necessary for intubated/catheterized patients to prevent secondary infections.

VI. Comprehensive Dosage Table

Drug Name	Dosage / Route	Indications & Considerations
BENZODIAZEPINES
Alprazolam (Xanax)	0.25–0.5 mg PO t.i.d. up to 1–10 mg/day; reduce dose in elderly.	Anxiety, panic attacks. Onset: 30 min. Taper after long-term therapy.
Chlordiazepoxide (Librium)	5–25 mg PO t.i.d. to q.i.d.; or 50–100 mg IV or IM.	Anxiety, alcohol withdrawal, preoperative. Duration: 2-3 days. Monitor injection sites.
Clorazepate (Tranxene)	15–60 mg/day in divided doses.	Anxiety, alcohol withdrawal, partial seizures. Taper dosage.
Diazepam (Valium)	Adult: 2–10 mg PO b.i.d. to q.i.d.; or 2–30 mg IM/IV.	Anxiety, alcohol withdrawal, muscle relaxant, antiepileptic. Drug of choice if route change anticipated.
Estazolam (ProSom)	1 mg PO at bedtime.	Hypnotic for insomnia. Monitor liver/renal function long-term.
Flurazepam (Dalmane)	30 mg PO at bedtime (15 mg in elderly).	Hypnotic for insomnia. Long-lasting.
BARBITURATES
Amobarbital (Amytal sodium)	65–500 mg IM or IV.	Sedative-hypnotic, convulsions. Monitor carefully via IV.
Butabarbital (Butisol)	15–30 mg PO t.i.d. to q.i.d.; 50-100 mg at bedtime.	Short-term sedative-hypnotic. May produce excitability in children.
Pentobarbital (Nembutal)	20 mg PO t.i.d. to q.i.d.; 100 mg at bedtime; 150-200 mg IM.	Sedative-hypnotic, preanesthetic. Give IV slowly.
Phenobarbital (Luminal)	30–120 mg/day PO, IM, or IV.	Long-acting. Seizure control, sedation. Highly effective for grand mal.
Secobarbital (Seconal)	100–300 mg PO.	Preanesthetic, acute convulsive seizures (tetanus). Rapid onset.
OTHER ANXIOLYTICS & HYPNOTICS
Buspirone (BuSpar)	Oral drug for anxiety.	Lacks sedative, anticonvulsant, and muscle-relaxant properties. No dependence. May cause dry mouth/headache. Takes weeks to reach full effect.
Zolpidem (Ambien)	Oral drug for short-term insomnia.	Z-Drug. Binds selectively to BDZ receptor subtype (Alpha-1). No anticonvulsant/muscle relaxing properties. Minimal rebound insomnia. Withdraw gradually.
Zaleplon (Sonata)	Oral for short-term insomnia.	Similar to Zolpidem. Take right before bed (devote 4-8 hours to sleep).
Eszopiclone (Lunesta)	Oral for insomnia.	Tablet must be swallowed whole. Allow 8 h for sleep.
Diphenhydramine (Benadryl) / Promethazine	PO, IM, or IV.	Antihistamines. Highly sedating. Used as sleep aids or pre-op. Monitor for thickened respiratory secretions (anticholinergic drying effect).
Chloral Hydrate	PO or PR.	Nocturnal sedation, preoperative sedation. Withdraw gradually over 2 weeks.
Ramelteon (Rozerem)	Oral.	Melatonin receptor agonist. For difficulty falling asleep. Take 30 min before bed.
Meprobamate (Miltown)	Oral.	Short-term management of anxiety. High risk of addiction.
Dexmedetomidine (Precedex)	IV.	Used for newly intubated/ventilated patients in ICU. Alpha-2 agonist. Do not use longer than 24h.

NURSING CARE PLAN & SPECIAL CONSIDERATIONS

General Nursing Interventions for Anxiolytics & Hypnotics

Parenteral Administration Rules: Do not administer intra-arterially (causes severe arteriospasm and gangrene). Monitor injection sites carefully for phlebitis. Give IV drugs very slowly because rapid administration is associated with hypotension, bradycardia, and cardiac arrest. Do not mix IV drugs in solution with other drugs to avoid precipitation and interactions.
Transitioning Therapy: Give parenteral forms only if oral forms are not feasible, and switch to oral forms (which are safer and have fewer adverse effects) as soon as possible.
Narcotic Adjustments: Arrange to reduce the dose of narcotic analgesics in patients receiving a benzodiazepine or barbiturate to decrease potentiated CNS and respiratory depression.
Mobility and Safety: Maintain patients who receive parenteral agents in bed for at least 3 hours. Do not permit ambulatory patients to operate a motor vehicle or heavy machinery. Institute fall precautions (side rails, assistance with ambulation).
Long-Term Monitoring: Monitor hepatic and renal function, as well as CBC, during long-term therapy to detect dysfunction. If noted, arrange to taper and discontinue the drug.
Withdrawal Prevention: Never abruptly stop long-term therapy. Taper dose gradually, especially in epileptic patients. Acute withdrawal could precipitate fatal status epilepticus or severe withdrawal syndrome.
Comfort Measures: Have patients void before dosing. Institute a bowel program as needed. Give food with the drug if GI upset is severe. Provide environmental control (dim lighting, quiet room, temperature regulation) to enhance sleep hygiene and drug efficacy.
Patient Education: Provide thorough teaching including the drug name, prescribed dose, avoidance of alcohol and OTC depressants, warning signs of toxicity, and the need for periodic lab monitoring to promote compliance.
Emergency Preparedness: Always provide standby life-support facilities (resuscitation equipment, intubation tray) in case of severe respiratory depression or hypersensitivity reactions. Keep the antidote (Flumazenil) readily available for BDZ overdoses.

Common Nursing Diagnoses

No.	Nursing Diagnosis	Intervention / Rationale
1	Risk for Injury / Falls related to central nervous system depression, drowsiness, ataxia, and confusion.	Implement rigorous fall precautions. Instruct the patient to call for assistance before getting out of bed. Keep the bed in the lowest position with side rails up. CNS depressants impair motor coordination and judgment, dramatically increasing fall risk, especially in the elderly.
2	Impaired Gas Exchange / Ineffective Breathing Pattern related to dose-dependent respiratory depression (particularly with IV barbiturates/BDZs).	Continuously monitor respiratory rate, depth, and oxygen saturation. Maintain an open airway. Have emergency airway equipment nearby. These agents depress the medullary respiratory center. Hypoxia and hypercapnia can occur rapidly, leading to respiratory arrest.
3	Deficient Knowledge regarding safe drug usage, avoidance of interactions (alcohol), and withdrawal risks.	Educate the patient to strictly avoid alcohol and unprescribed antihistamines. Teach the importance of not abruptly stopping the medication. Combining CNS depressants is synergistic and potentially fatal. Abrupt cessation leads to rebound nervous system hyperactivity and seizures.
4	Disturbed Sleep Pattern related to underlying anxiety, medication "hangover" effect, or REM sleep rebound.	Teach proper sleep hygiene (avoiding caffeine/screens at night). Assess the effectiveness of the hypnotic agent. Reassure the patient that vivid dreams may occur upon discontinuation. While these drugs induce sleep, they alter the natural sleep architecture. REM rebound causes intense nightmares when the drug is stopped.

VIII. References

Deore, A. B. (n.d.). Sedative, Hypnotic and Anxiolytic Drugs [PDF Presentation slides]. MVP’s Institute of Pharmaceutical Sciences, Nashik.
Katzung, B. G. (2017). Basic & Clinical Pharmacology (14th ed.). McGraw-Hill Education.
Brunton, L. L., Hilal-Dandan, R., & Knollmann, B. C. (2017). Goodman & Gilman's The Pharmacological Basis of Therapeutics (13th ed.). McGraw-Hill Education.
Karch, A. M. (2019). Focus on Nursing Pharmacology (8th ed.). Wolters Kluwer.

Quick Quiz

Anxiolytics & Hypnotics Quiz

Pharmacology - mobile-friendly and focused practice.

Full Name Email Address

Privacy: Your details are used only for quiz tracking and certificates.

Anxiolytic and Hypnotic Agents Read More »

Transverse Myelitis

Transverse Myelitis (TM)

Transverse myelitis (TM) is a rare but serious neurological condition caused by inflammation of the spinal cord.

This inflammation leads to the formation of scars or lesions that disrupt communication between the nerves of the spinal cord and the rest of the body.

The term “transverse“ refers to the fact that the inflammation can spread across the width of the spinal cord. However, in some cases, the swelling may only affect a portion of the spinal cord’s width. TM can occur at any age and affects both children and adults.

Signs and Symptoms of Transverse Myelitis

Symptoms of transverse myelitis typically develop over a few hours to several weeks. They can vary depending on the severity and location of the inflammation. Common signs and symptoms include:

1. Motor Symptoms (Affecting Movement)

Muscle weakness in the legs, and sometimes the arms
Mobility problems, including difficulty walking or paralysis (paraplegia or quadriplegia)
Muscle spasms or involuntary muscle contractions (spasticity)

2. Sensory Symptoms (Affecting Sensation)

Tingling, numbness, or unusual sensations (burning, prickling, or coldness) in the legs, arms, or torso
Loss of sensation in affected areas
Heightened sensitivity to touch, temperature, or pain.

3. Autonomic Dysfunction (Affecting Involuntary Functions)

Bladder dysfunction (incontinence, urinary retention, or frequent urination)
Bowel dysfunction (constipation or incontinence)
Sexual dysfunction (erectile dysfunction in men, loss of sensation in women)

4. Pain Symptoms

Sharp or shooting pain in the lower back, chest, or limbs
Chronic neuropathic pain, which can persist even after inflammation subsides

In severe cases, TM can lead to complete paralysis and loss of all sensory functions below the affected area of the spinal cord.

Types of Transverse Myelitis

Transverse myelitis can be classified into different types based on how quickly symptoms develop and their duration:

1. Acute Transverse Myelitis (ATM)

The most common form of TM.
Symptoms develop suddenly, often within a few hours or days.
Can lead to rapid deterioration and may require urgent medical intervention.

2. Subacute Transverse Myelitis (STM)

Symptoms develop gradually over several weeks to months.
Less aggressive than ATM but still causes significant neurological issues.

3. Chronic Transverse Myelitis (CTM)

Symptoms persist for six months or longer.
Can lead to long-term disability due to persistent nerve damage.

Causes of Transverse Myelitis

Transverse myelitis can result from autoimmune disorders, infections, or other underlying conditions. In many cases, the exact cause remains unknown (idiopathic transverse myelitis).

1. Autoimmune Disorders

In some cases, TM is caused by an autoimmune reaction, where the immune system mistakenly attacks the body’s own nerve tissues. Autoimmune diseases that can trigger TM include:

Neuromyelitis optica (NMO) – A condition that affects both the spinal cord and optic nerves.
Myelin oligodendrocyte glycoprotein (MOG)-associated myelitis – A demyelinating disorder affecting the central nervous system.
Sarcoidosis – An inflammatory disease that can affect multiple organs, including the nervous system.
Sjögren’s syndrome – A chronic autoimmune disease affecting moisture-producing glands and sometimes the nervous system.
Systemic lupus erythematosus (lupus) – An autoimmune disease that can cause inflammation throughout the body, including the spinal cord.

2. Viral Infections

Certain viral infections can lead to TM, either directly attacking the nervous system or triggering an immune response that causes spinal cord inflammation. These include:

Enteroviruses (e.g., echovirus
Epstein-Barr virus (EBV)
Hepatitis A
Herpes simplex virus (HSV)
Human immunodeficiency virus (HIV)
Influenza virus (flu)
Rubella virus
Varicella-zoster virus (causes chickenpox and shingles)

3. Bacterial Infections

Some bacterial infections can also contribute to transverse myelitis, including:

Syphilis – A sexually transmitted infection that can affect the nervous system in its later stages.
Lyme disease – Caused by Borrelia burgdorferi bacteria transmitted through tick bites.
Tuberculosis – A bacterial infection that primarily affects the lungs but can also involve the nervous system.

4. Cancer (Paraneoplastic Syndrome)

Certain cancers may trigger an abnormal immune response, leading to inflammation of the spinal cord. This is known as paraneoplastic transverse myelitis and can occur in cancers such as:

Lung cancer
Breast cancer
Lymphomas

Diagnosing Transverse Myelitis

Diagnosis of transverse myelitis requires a combination of clinical evaluation and diagnostic tests to confirm spinal cord inflammation and rule out other conditions.

1. Neurological Examination: Assess reflexes, muscle strength, coordination, and sensory responses to determine the extent of spinal cord dysfunction.

2. Magnetic Resonance Imaging (MRI) Scan : MRI scans of the spine help identify lesions, swelling, and inflammation in the spinal cord.

MRI of the brain may be done to check for conditions like multiple sclerosis (MS) or neuromyelitis optica (NMO).

3. Lumbar Puncture (Spinal Tap): Cerebrospinal fluid (CSF) analysis can detect inflammation, infections, or autoimmune activity.

Elevated white blood cell counts or abnormal proteins may indicate infection or immune system dysfunction.

4. Blood Tests: Blood tests help detect infections, autoimmune markers, and vitamin deficiencies that might contribute to TM.

Specific antibody tests can help identify conditions like neuromyelitis optica (NMO-IgG antibody test) or MOG-associated myelitis.

5. Additional Imaging and Tests

Computed Tomography (CT) Scan – Used if MRI is unavailable or to rule out other spinal conditions.
Evoked Potential Tests – Measures how quickly nerves respond to stimulation.

Management of Transverse Myelitis (TM)

The management of transverse myelitis involves a multidisciplinary approach aimed at reducing inflammation, managing symptoms, preventing complications, and promoting functional recovery.

Aims of Management

The main objectives in managing transverse myelitis include:

Reducing inflammation in the spinal cord to minimize nerve damage.
Alleviating symptoms such as pain, muscle weakness, and bowel/bladder dysfunction.
Restoring mobility and function through rehabilitation therapies.
Preventing complications such as pressure sores, infections, and contractures.
Addressing underlying causes such as autoimmune disorders or infections.

1. Acute Phase Management (Hospital Admission and Initial Treatment)

A. Admission and Monitoring

Patients with suspected transverse myelitis are typically admitted to a hospital for close monitoring. Initial care includes:

Vital signs monitoring, especially respiratory function and cardiovascular status.
Neurological assessment to evaluate the severity and progression of symptoms.
Bladder and bowel assessment to manage dysfunctions early.

B. Medical Treatment

1. Corticosteroids (First-line Treatment)

High-dose intravenous corticosteroids (e.g., methylprednisolone) are administered to reduce inflammation and prevent further spinal cord damage.
If effective, an oral steroid taper may be given over weeks to prevent recurrence.
Side effects include increased infection risk, mood changes, stomach irritation, and weight gain.

2. Plasma Exchange Therapy (Plasmapheresis)

Used for patients who do not respond to corticosteroids.
Helps remove harmful autoantibodies from the blood.
Typically done over 5-7 sessions.

3. Immunomodulatory Therapy

For autoimmune-related TM, immunosuppressants such as azathioprine, rituximab, or cyclophosphamide may be required.

4. Antiviral or Antibiotic Therapy

If an infection (viral or bacterial) is suspected, appropriate antiviral (e.g., acyclovir) or antibiotic (e.g., ceftriaxone) treatment is given.

5. Symptomatic Treatment (Pain and Spasticity Management)

Neuropathic pain is managed with gabapentin, pregabalin, or amitriptyline.
Muscle spasms and stiffness are treated with baclofen, tizanidine, or diazepam.

2. Symptom Management and Rehabilitation

A. Managing Muscle Weakness and Mobility Issues

Muscle weakness and paralysis significantly impact mobility and independence. Treatment includes:

Physical therapy to improve muscle strength, coordination, and endurance.
Stretching and strengthening exercises to prevent contractures.
Use of mobility aids (e.g., walkers, canes, wheelchairs) for movement support.
Occupational therapy to enhance daily activities and recommend home modifications (e.g., stair lifts, grab bars).

B. Bladder Dysfunction Management

1. Overactive bladder treatment: Anticholinergic medications like oxybutynin or tolterodine.

2. Urinary retention treatment:

Intermittent self-catheterization (ISC) to empty the bladder as needed.
Indwelling catheterization for patients with severe dysfunction.
Hand-held external stimulators may help initiate urination.

C. Bowel Dysfunction Management

Constipation: High-fiber diet, increased fluid intake, and laxatives (e.g., lactulose, bisacodyl).
Severe constipation: May require suppositories or enemas.
Bowel incontinence: Pelvic floor exercises and medications like loperamide for diarrhea control.

D. Pain Management

1. Neuropathic Pain (Nerve-Related Pain) Treatment

Anticonvulsants: Gabapentin, pregabalin.
Tricyclic antidepressants: Amitriptyline, nortriptyline.

2. Musculoskeletal Pain Management

Physical therapy: Exercises, proper seating posture.
Pain relievers: NSAIDs (e.g., ibuprofen) or stronger analgesics if needed.
Transcutaneous Electrical Nerve Stimulation (TENS): May help alleviate chronic pain.

E. Sexual Dysfunction Management

Men with erectile dysfunction: PDE-5 inhibitors (e.g., sildenafil).
Women with decreased libido: Psychological counseling and sexual therapy.
Relationship counseling: Helps couples adjust to changes in intimacy.

3. Nursing Management of Transverse Myelitis

Nursing care focuses on supportive management, preventing complications, and assisting with rehabilitation.

A. Nursing Diagnoses and Interventions

Nursing Diagnosis	Interventions
Impaired physical mobility (related to muscle weakness/spasticity)	– Assist with physical therapy. – Provide mobility aids. – Prevent contractures with passive ROM exercises.
Risk for skin breakdown (due to immobility and pressure ulcers)	– Reposition every 2 hours. – Use pressure-relieving mattresses. – Keep skin dry and moisturized.
Urinary retention/incontinence	– Assist with catheterization. – Monitor fluid intake. – Teach bladder training techniques.
Bowel incontinence or constipation	– Encourage high-fiber diet and hydration. – Assist with bowel training.
Chronic pain (related to nerve damage)	– Administer prescribed analgesics. – Provide warm compresses or TENS therapy.
Risk for infection (due to catheterization, immunosuppressants)	– Follow aseptic techniques. – Monitor for fever and signs of infection.

B. Psychological and Emotional Support

Patients with TM may experience anxiety, depression, and frustration due to mobility loss.
Counseling and mental health support can help cope with emotional challenges.
Support groups allow patients to connect with others facing similar challenges.

4. Preventing Complications

Complications of transverse myelitis can be serious and life-threatening. Preventative strategies include:

Complication	Prevention Strategies
Pressure ulcers	Regular repositioning, skin assessments, pressure-relieving mattresses.
Deep vein thrombosis (DVT)	Compression stockings, anticoagulants, leg exercises.
Urinary tract infections (UTIs)	Proper catheter care, increased hydration, bladder training.
Respiratory failure	Respiratory exercises, mechanical ventilation if needed.
Chronic pain	Early pain management, physiotherapy, psychological counseling.

Transverse Myelitis Read More »

Antineoplastic Agents

ANTINEOPLASTIC AGENTS

Antineoplastic agents are a class of drugs designed to combat cancer by inhibiting the growth and proliferation of neoplastic cells (cancer cells). Also called Anticancer drugs.

The action of antineoplastic agents can be broadly categorized into two main mechanisms: affecting cell survival and enhancing the immune system’s ability to fight abnormal cells.

Common Terminology

Alopecia: Hair loss, a common side effect due to the drug’s action on rapidly dividing cells.
Angiogenesis: Formation of new blood vessels, which cancer cells induce to supply themselves with nutrients.
Carcinoma: A type of cancer that starts in epithelial cells.
Metastasis: The spread of cancer cells from the original site to other parts of the body.
Neoplasm: An abnormal growth of tissue, which can be benign or malignant (cancerous).
Sarcoma: A type of cancer that arises from connective tissues such as bone, muscle, and fat.
Anaplasia: loss of organization and structure; property of cancer cells.
Cancer: refers to a malignant neoplasm or new growth

Cancer can be divided into;

Solid tumors
Hematological

Solid Tumors; can further be differentiated into carcinomas, or tumors that originate in epithelial cells, and sarcomas, or tumors that originate in the mesenchyme and are made up of embryonic connective tissue cells.

Haematological Malignancies; involve blood forming organs of the body, the bone marrow, the lymphatic system. These malignancies alter the body’s ability to produce and regulate the cells found in the blood.

Classification of Antineoplastic Agents:

Alkylating Agents: Interfere with DNA replication, most effective against slow-growing cancers.
Antimetabolites: Resemble natural substances within the cell, disrupting DNA and RNA synthesis.
Antineoplastic Antibiotics: Bind to DNA and prevent RNA synthesis, primarily affecting rapidly growing cells.
Mitotic Inhibitors: Block cell division (mitosis), preventing the replication of cancer cells.
Hormones and Hormone Modulators: Block or mimic hormones to inhibit the growth of hormone-sensitive tumors.
Cancer Cell-Specific Agents: Target specific molecules involved in cancer cell growth and survival, minimizing damage to normal cells.
Miscellaneous Antineoplastics: A diverse group with varying mechanisms of action, often used when other treatments are ineffective.

Starts with G1 Phase: where the cell grows in size and releases enzymes for DNA replication. Cells may not progress hence remain at G0 phase.
S Phase: Synthetic Phase: Where DNA replication occurs, cells make identical copies of their own chromosomes.
G2 Phase: Check Point, When passed, they continue to grow and prepare themselves to divide.
Mitosis Phase: where cell division occurs

Prophase: Chromosomes appear condensed and the nuclear envelope breaks down.
Metaphase: Where microtubules in the center align,
Anaphase: Chromosomes are separated
Telophase: 2 daughter cells formed
Cytokinesis: Either they become dormant(Gap 0) , or continue to G1 phase to create another cell division.

Types of Antineoplastic Drugs

Alkylating Agents/DNA Replication Inhibitors

Alkylating agents work by adding an alkyl group to the DNA, thereby preventing the DNA strands from uncoiling and replicating. This is particularly effective in treating slow-growing cancers.

Indications:

Lymphomas
Leukemias
Myelomas
Ovarian, testicular, and breast cancers
Pancreatic cancer
Pulmonary carcinoma (lung cancer)
Rheumatoid arthritis

Contraindications:

Pregnancy and lactation (due to severe effects on the fetus and neonate)
Bone marrow suppression
Renal and hepatic dysfunction

Adverse Effects:

Gastrointestinal (GI): Nausea, vomiting, diarrhea, mucous membrane deterioration
Genitourinary (GU): Renal toxicity, increased uric acid levels
Hematological: Bone marrow suppression, leading to anemia, thrombocytopenia, and leukopenia
Alopecia

Examples of Alkylating Agents:

Drug	Indications	Dosage
Cyclophosphamide (Cytoxan, Neosar)	Lymphomas, Leukemias, Myelomas, Breast cancer	Induction: 40–50 mg/kg per day IV over 2–5 days; Maintenance: 1–5 mg/kg per day Orally/IV
Busulfan (Busulfex, Myleran)	Chronic myelogenous leukemia (CML), Lymphomas	Induction: 4–8 mg/d Orally; Maintenance: 1–3 mg/d Orally
Chlorambucil (Leukeran)	Hodgkin’s disease, Non-Hodgkin’s lymphoma	0.1–0.2 mg/kg per day Orally for 3–6 weeks; Maintenance: 0.03–0.1 mg/kg per day Orally

Antimetabolites

Antimetabolites mimic natural substances within the cell, interfering with DNA and RNA synthesis. These drugs are most effective against rapidly proliferating cells.

Indications:

Leukemias
Gastrointestinal cancers
Breast, stomach, pancreas, and colon cancer

Contraindications:

Pregnancy and lactation
Bone marrow suppression
Renal and hepatic dysfunction
GI ulceration

Adverse Effects:

CNS: Headache, drowsiness, dizziness
Respiratory: Pulmonary toxicity, interstitial pneumonitis
Hematological: Bone marrow suppression
GI: Nausea, vomiting, diarrhea, hepatic toxicity
GU: Renal toxicity

Examples of Antimetabolites:

Drug	Indications	Dosage
Methotrexate (Rheumatrex, Trexall)	Leukemias, Rheumatoid arthritis	15–30 mg Orally/IM depending on the disease being treated
Fluorouracil (Adrucil, Carac)	Breast, stomach, colon cancer	12 mg/kg per day IV on days 1–4, then 6 mg/kg IV on days 6, 8, 10, and 12

Antineoplastic Antibiotics

These drugs bind to DNA and inhibit RNA synthesis, primarily targeting rapidly dividing cells.

Indications:

Testicular cancer
Lymphomas
Squamous cell carcinoma
Choriocarcinoma

Contraindications:

Pregnancy and lactation
Bone marrow suppression
Renal and hepatic dysfunction
Pre-existing pulmonary or cardiac conditions

Adverse Effects:

CNS: Headache, drowsiness, dizziness
Respiratory: Pulmonary toxicity
Hematological: Bone marrow suppression
GI: Nausea, vomiting, hepatic toxicity
GU: Renal toxicity
Alopecia

Examples of Antineoplastic Antibiotics:

Drug	Indications	Dosage
Bleomycin (Blenoxane)	Testicular cancer, Lymphoma	Test dose of 1-2 units given 2-4 hours before therapy; 0.25–0.5 units/kg IM, IV, or SC once/twice weekly
Doxorubicin (Adriamycin, Doxil)	Breast cancer, Kaposi’s sarcoma	60–75 mg/m2 as a single IV dose; repeat every 21 days

Mitotic Inhibitors/Vinca Alkaloids

Mitotic inhibitors block cell division by inhibiting mitosis, specifically targeting the M phase of the cell cycle.

Indications:

Leukemia
Lymphomas (e.g., Hodgkin’s lymphoma)
Kaposi’s sarcoma
Testicular and breast cancer

Contraindications:

Pregnancy and lactation
Bone marrow suppression
Renal and hepatic dysfunction
GI ulceration

Adverse Effects:

CNS: Headache, drowsiness, dizziness
Hematological: Bone marrow suppression
GI: Nausea, vomiting, mucous membrane deterioration
GU: Renal toxicity
Alopecia
Neuropathy, stomatitis, constipation

Examples of Mitotic Inhibitors:

Drug	Indications	Dosage
Vincristine (Oncovin, Vincasar)	Leukemia, Lymphoma	Adult: 1.4 mg/m2 IV at weekly intervals
Vinblastine (Velban)	Hodgkin’s disease, Lymphoma	Adult: 3.7 mg/m2 IV once weekly; Pediatric: 2.5 mg/m2 IV once weekly

Hormones and Hormone Modulators

Some cancers, particularly those involving the breast tissue, ovaries, uterus, prostate, and testes, are sensitive to estrogen stimulation. Estrogen-receptor sites on the tumor react with circulating estrogen, and this reaction stimulates the tumor cells to grow and divide

Hormones and hormone modulators block or interfere with these receptor sites to prevent growth of the cancer and cause cell death.

Some hormones are used to block the release of gonadotropic hormones in breast or prostate cancer if the tumors are responsive to gonadotropic hormones. Others may block androgen-receptor sites directly.

Indications:

Breast cancer in postmenopausal women
Prostate cancer

Contraindications and Cautions

Known allergy to drug: Prevent hypersensitivity reactions
Hypercalcemia: Contraindication to the use of toremifene because the drug can increase serum calcium
Pregnancy and lactation: Severe effects on the fetus and neonate
Bone marrow suppression: Index of re-dosing and dosing levels
Renal and hepatic dysfunction: Interfere with drug metabolism and excretion
Known GI ulceration or ulcerative diseases: Can be exacerbated by the effects of the drug.

Adverse Effects:

Menopausal symptoms: Hot flashes, vaginal dryness, mood changes
Hematological: Bone marrow suppression
GI: Hepatic toxicity
GU: Renal toxicity
Hypercalcemia

Examples of Hormones and Hormone Modulators:

Drug	Indications	Dosage
Tamoxifen (Nolvadex)	Breast cancer	20–40 mg Orally per day
Anastrozole (Arimidex)	Breast cancer in postmenopausal women	1 mg Orally per day

Quick Quiz

Anticancer Drugs Quiz

Pharmacology - mobile-friendly and focused practice.

Full Name Email Address

Privacy: Your details are used only for quiz tracking and certificates.

Incase You Needd Detailed, 👇👇👇👇👇

Comprehensive Antineoplastic Agents (Anticancer Drugs)

Antineoplastic agents are a class of drugs designed to combat cancer by inhibiting the growth and proliferation of neoplastic cells (cancer cells). They are also commonly referred to as Anticancer drugs or Chemotherapy.

The action of antineoplastic agents can be broadly categorized into two main mechanisms: affecting cell survival (cytotoxicity) and enhancing the immune system’s ability to fight abnormal cells (immunotherapy/targeted therapy).

I. Historical Timeline & Treatment Options

Before 1940: No effective treatment available for systemic cancers.
Before 1955: Surgery was the primary and only definitive treatment.
1955–1965: Radiotherapy became widely established.
After 1965: The advent and widespread use of systemic Chemotherapy.
Modern Era: Introduction of Immunotherapy and Gene Therapy, revolutionizing targeted cancer treatment.

Cell Cycle Effects of Anticancer Drugs

Cell Cycle Phase	Cell Cycle Specific (CCS) Drugs	Cell Cycle Non-Specific (CCNS) Drugs
G1 - S Phase	Etoposide	These agents affect cells across all phases: ➔ Platinum compounds (Cisplatin, Carboplatin) ➔ Alkylating agents (Cyclophosphamide, Busulfan, Nitrosoureas) ➔ Antibiotics (Anthracyclines, Dactinomycin, Mitomycin) ➔ Camptothecins
S Phase	Antimetabolites (Methotrexate, 5-FU, Cytarabine, 6-MP)
G2 - M Phase	Bleomycin, Etoposide
M Phase (Mitosis)	Vinca alkaloids, Taxanes, Ixabepilone, Estramustine

II. Goals and General Principles of Therapy

A. Goals of Therapy

Cure or induce prolonged "remission": Macroscopic and microscopic features of the cancer disappear entirely. Highly achievable in: Acute Lymphoblastic Leukaemia (ALL), Wilm's tumor, Ewing's sarcoma, Hodgkin's lymphoma (in children), testicular teratoma, and choriocarcinoma.
Palliation: Aimed at the shrinkage of an evident tumor, alleviation of symptoms, and prolongation of life rather than absolute cure. Targeted for: Breast cancer, ovarian cancer, endometrial carcinoma, CLL, CML, Small cell lung cancer (SCLC), and Non-Hodgkin lymphoma.
Insensitive Tumors: These are less sensitive to chemotherapy, but life may still be prolonged. Includes: Cancer of the esophagus, cancer of the stomach, squamous cell carcinoma of the lung, melanoma, pancreatic cancer, myeloma, and colorectal cancer.
Adjuvant Therapy: Used routinely now for "mopping up" residual cancer cells, including micrometastases, after surgery or radiation. Mainly utilized in solid tumors.

B. General Principles of Chemotherapy

It is analogous to Bacterial chemotherapy but with critical differences:
- Selectivity of drugs is highly limited (they attack normal host cells as well).
- No or less defense mechanism (the host immune system does not recognize cancer as readily as bacteria; cytokines are used as adjuvants now to boost this).
The goal is to kill all malignant cells to stop progeny.
Tumors contain subpopulations of cells that differ in their rate of proliferation and susceptibility to chemotherapy.
Total Tumor Cell Kill via COMBINATION CHEMOTHERAPY: Formerly, single drugs were used; now, 2-5 drugs are used in intermittent pulses.

Why Combination Chemotherapy is Synergistic:

Utilizes drugs which are effective when used alone.
Combines drugs with different mechanisms of action.
Combines drugs with differing toxicities (and different mechanisms of toxicities) to prevent overlapping fatal side effects (e.g., combining bone marrow-sparing Bleomycin with a myelosuppressive agent).
Utilizes synergistic biochemical interactions.
Applies an optimal schedule determined by trial and error, relying heavily on cell cycle specificity.

C. Drug Resistance

Intrinsic Resistance: Tumors naturally possess primary resistance without prior exposure. Examples: Malignant melanoma, renal cell cancer, and brain cancer.
Acquired Resistance: Develops after initial exposure.
- Single drug resistance: Change in the genetic apparatus, amplification, or increased expression of one or more specific genes targeted by the drug.
- Multidrug resistance (MDR): Resistance to a wide variety of drugs after exposure to a single variety. Often due to increased expression of a normal gene (the MDR1 gene) which codes for a cell surface glycoprotein (P-glycoprotein) involved in active drug efflux (pumping the drug out of the cell).

III. Toxicities and Countering Agents

Chemotherapy is harmful to normal tissues because it has a steep dose-response curve and a low therapeutic index. It is particularly harmful to rapidly multiplying normal tissues (GI mucosa, Bone Marrow, Reticuloendothelial [RE] system, gonads, and hair cells). Effects occur in a dose-dependent manner.

General Toxicities:

Bone Marrow Depression (BMD): Leukopenia, thrombocytopenia, anemia. This is the primary dose-limiting toxicity for most treatments.
Buccal Mucosa Erosion: High epithelial turnover leads to stomatitis, severe mucositis, and bleeding gums.
Gastrointestinal (GIT): Diarrhea, shedding of mucosa, hemorrhage. Nausea and vomiting are severe due to direct stimulation of the Chemoreceptor Trigger Zone (CTZ).
Skin: Alopecia (hair loss).
Gonads: Oligospermia, impotence, amenorrhoea, and permanent infertility.
Lymphoreticular System: Lymphocytopenia and inhibition of lymphocyte function, leading to a loss of host defense mechanisms and extreme susceptibility to infections.
Other systemic: Carcinogenicity (secondary tumors), Teratogenicity, and Hyperuricemia (due to rapid tumor cell lysis releasing purines).

Distinctive Toxicities of Alkylating Agents & Others:

Drug	Distinctive Toxicity
Cyclophosphamide	Alopecia, Hemorrhagic cystitis, SIADH (Syndrome of Inappropriate Antidiuretic Hormone).
Ifosfamide	Hemorrhagic cystitis, SIADH.
Busulfan	Pulmonary fibrosis ("Busulfan lung"), Hyperpigmentation, Adrenal insufficiency, Tonic-clonic seizures.
Procarbazine	Secondary leukemias, Disulfiram-like reaction (with alcohol), behavioral changes, CNS depression.
Cisplatin	Severe Emesis, Nephrotoxicity, Peripheral sensory neuropathy, Ototoxicity (deafness).

Pharmacological Interventions to Prevent/Counter Toxicity (Rescue Therapies)

Toxicities are countered via intermittent therapy (giving normal cells time to recover) and specific pharmacological rescue agents:

Drug (Rescue/Preventive Agent)	Mechanism of Action	Indications / Used For
Allopurinol	Inhibits xanthine oxidase.	Prevents hyperuricemia from massive tumor lysis syndrome.
Rasburicase	Recombinant urate oxidase (converts uric acid to soluble allantoin).	Prevents hyperuricemia from rapid tumor lysis.
Mesna (Sodium-2-mercaptoethane sulfonate)	Neutralizing agent (binds toxic metabolite acrolein).	Prevents hemorrhagic cystitis due to Ifosfamide and high-dose Cyclophosphamide.
Leucovorin (Folinic Acid)	Repletes Tetrahydrofolic acid directly.	"Leucovorin Rescue" after high-dose Methotrexate to save bone marrow and GIT mucosa.
Amifostine	Scavenges free radicals.	Prevents radiation-induced xerostomia and Cisplatin-induced nephrotoxicity.
Dexrazoxane	Iron chelator.	Prevents cardiotoxicity due to Anthracyclines (Doxorubicin, Daunorubicin).
Palifermin	Keratinocyte growth factor.	Prevents severe mucositis following heavy chemotherapy.
Pilocarpine	Cholinergic agonist.	Treats radiation-induced xerostomia (dry mouth).
Pamidronate / Zoledronate	Bisphosphonates.	Treats hypercalcemia of malignancy and bone metastases.
Epoetin alpha / Darbepoetin	Recombinant Erythropoietin.	Treats chemotherapy-induced anemia.
Filgrastim / Peg-filgrastim	G-CSF (Granulocyte Colony-Stimulating Factor).	Febrile neutropenia prophylaxis; speeds recovery of granulocytopenia.
Sargramostim	GM-CSF (Granulocyte-Macrophage CSF).	Myeloid reconstitution.
Oprelvekin	IL-11 (Interleukin-11).	Treats severe chemotherapy-induced thrombocytopenia.
Ondansetron / Granisetron / Palonosetron	5-HT3 antagonists.	Prevents acute nausea and vomiting.
Aprepitant	NK-1 (Neurokinin-1) receptor antagonist.	Prevents Cisplatin-induced delayed vomiting.

IV. Detailed Classification & Pharmacology of Antineoplastic Agents

Classification is based on chemical structure, biochemical mechanism of action (blocking nucleic acid synthesis, interfering with DNA structure, blocking RNA/protein synthesis, influencing hormones), and cell cycle phase specificity.

1. Alkylating Agents & Platinum Compounds (CCNS)

Mechanism of Action: They act by binding irreversibly to nucleic acids (DNA). Nitrogen mustards inhibit cell reproduction by adding an alkyl group. Bifunctional alkylating agents cause intrastrand linking and cross-linking of the DNA double helix (sugar-phosphate backbone).
After alkylation, DNA is unable to replicate and cannot synthesize proteins or essential cell metabolites. Consequently, cell reproduction is inhibited, metabolic functions fail, and the cell eventually dies.

Subgroups of Alkylating Agents:

Nitrogen Mustards: Mechlorethamine, Cyclophosphamide, Ifosfamide, Melphalan, Chlorambucil.
- Mechlorethamine: The first alkylating agent employed clinically. Bifunctional (crosslinks DNA). Extremely unstable and is inactivated within a few minutes following administration, thus given IV. Used in MOPP regimen for Hodgkin's disease. Highly vesicant (severe local toxicity on extravasation). ADRs: Severe vomiting, myelosuppression.
- Cyclophosphamide: A prodrug transformed into active aldophosphamide and phosphoramide mustard in the liver. Given orally or IV. Used for ALL, NHL, Polycythemia Vera, Hodgkin's lymphoma, breast and ovary cancers. Causes hemorrhagic cystitis (due to acrolein).
- Ifosfamide: Has a longer half-life, used mainly for testicular tumors. Also causes hemorrhagic cystitis.
- Chlorambucil: Orally active against lymphoid tissues. Preferred for CLL, Polycythemia Vera, and NHL.
- Melphalan: Oral agent used for Multiple Myeloma.
Alkyl Sulfonates:
- Busulfan: Orally active. Great effect for Chronic Granulocytic/Myelogenous Leukemia (CML). Delayed toxicities: Pulmonary infiltrates/fibrosis ("Busulfan lung"), tonic-clonic seizures in epileptics, skin pigmentation, adrenal insufficiency.
Nitrosoureas:
- Carmustine (BCNU) & Lomustine (CCNU): Bifunctional; active against broad spectrums of neoplastic disease. They inhibit synthesis of both DNA and RNA, as well as proteins. These drugs are highly lipophilic, easily crossing the blood-brain-barrier (BBB), making them excellent for primary and metastatic brain tumors. Also used for Hodgkin's, melanoma, and GI adenocarcinomas.
- Major Toxicity: Highly mutagenic/carcinogenic. Delayed bone marrow depression (prolonged leukopenia/thrombocytopenia), and pulmonary fibrosis.
Platinum Coordination Compounds:
- Cisplatin: Forms crosslinks within DNA strands. Very powerful IV agent against Testicular cancer, ovary, bladder, head, and neck carcinomas. Toxicity is severe: Renal tubular damage (minimized via massive hydration + amifostine), Ototoxicity, peripheral neuropathy, and VERY SEVERE vomiting (treated with Ondansetron/Aprepitant).
- Carboplatin: A derivative of cisplatin with significantly less nephrotoxicity, neurotoxicity, and ototoxicity (but higher myelosuppression).

2. Antimetabolites (CCS - S Phase)

These are structural analogues of essential metabolites that interfere with DNA/RNA synthesis (block nucleic acid biosynthesis). Myelosuppression is the primary dose-limiting toxicity.

A. Folic Acid Antagonists:

Methotrexate (MTX): Structure is similar to folic acid. It actively transports into mammalian cells and competitively inhibits dihydrofolate reductase (DHFR), the enzyme that normally converts dietary folate to the tetrahydrofolate required for thymidine and purine synthesis.
Kinetics & Indications: Orally, IM, IV, and intrathecally (for CSF entry). Used for ALL, Breast cancer, Tumors of head/neck, Meningeal metastases. It was the first demonstration of curative chemotherapy for Choriocarcinoma.
Leucovorin (Folinic acid) Rescue: Administered as part of high-dose MTX therapy. Leucovorin is directly converted to tetrahydrofolic acid (producing DNA/cellular protein) in spite of the presence of MTX, rescuing bone marrow and GIT mucosal cells from lethal toxicity.

B. Pyrimidine Antagonists:

5-Fluorouracil (5-FU): Analogue of thymine. Converted to 5-fluoro-2-deoxy-uridine monophosphate (5-FdUMP), which irreversibly inhibits thymidylate synthase. This blocks the conversion of deoxyuridylic acid to deoxythymidylic acid, causing failure of DNA synthesis. Used for solid tumors (breast, colorectal, gastric, head/neck). Toxicity: Hand and foot syndrome, severe oral/GI ulceration.
Cytarabine: Inhibits DNA polymerase. Used IV for Acute Myeloid Leukemia (AML). Delayed toxicity includes cerebellar ataxia (neurotoxicity).

C. Purine Antagonists:

6-Mercaptopurine (6-MP) & 6-Thioguanine (6-TG): Inhibit purine ring biosynthesis and nucleotide interconversions. 6-MP is used for childhood ALL maintenance and remission, and in combination with MTX for choriocarcinoma.
Important Interaction: 6-MP is metabolized by xanthine oxidase (which is inhibited by Allopurinol). If a patient is taking Allopurinol for hyperuricemia, the dose of 6-MP must be adjusted to ½ or ¼ to prevent fatal bone marrow toxicity. Well tolerated long term but causes mild hepatotoxicity.

D. Ribonucleoside Diphosphate Reductase Antagonist:

Hydroxyurea: Inhibits ribonucleotide reductase. Used orally for CML, AML (blast crisis), and Polycythemia vera.

3. Antineoplastic Antibiotics

Anthracyclines (Doxorubicin, Daunorubicin): Insert themselves into DNA causing breaks. They activate Topoisomerase II, causing DNA strand breaks, and generate excess free radicals (superoxide) causing DNA damage.
- Unique Toxicity: Known to irreversibly damage cardiac cells (Cardiomyopathy). Prevented with Dexrazoxane.
- Uses: Doxorubicin (Breast, ovary, lung, prostate, ALL, sarcomas, neuroblastoma). Daunorubicin (ALL, AML).
- Resistance: Develops due to increased efflux of drug via P-glycoprotein.
Bleomycin: Used for Carcinoma testis, malignant effusions, Hodgkin's. Toxicity: Pulmonary fibrosis, stomatitis, oedema of hands. Causes minimal myelosuppression (alopecia common).
Dactinomycin (Actinomycin D): Used for Wilm’s tumour.
Mitomycin C: Carcinoma stomach. Causes severe thrombocytopenia and leukopenia.
Streptozotocin: Targeted for Insulinoma (pancreatic islet cell tumors). Toxicity: Renal damage, hypoglycemia, nephrogenic diabetes insipidus.

4. Plant Alkaloids (Interfere with Protein Synthesis / Mitosis)

Antitubulin Agents:

Vinca Alkaloids (Vincristine, Vinblastine, Vinorelbine): Bind tubulin, destroy the spindle apparatus to produce mitotic arrest (M phase).
- Vincristine: ALL, NHL. Toxicity: Peripheral neuritis, alopecia, BMD.
- Vinblastine: Hodgkin's Disease. Toxicity: Loss of reflexes, BMD.
- Vinorelbine: Carcinoma lung. Toxicity: Paresthesia, hyporeflexia, fatigue.
Taxanes (Paclitaxel, Docetaxel): Stabilize microtubules, preventing disassembly.
- Paclitaxel: Carcinoma breast, ovary. Toxicity: Peripheral neuritis, BMD.
- Docetaxel: Advanced breast cancer. Toxicity: Fluid retention, neurotoxicity, neutropenia.

Topoisomerase Inhibitors:

Etoposide: A podophyllotoxin (toxin found in the mandrake root). Inhibits the enzyme Topoisomerase II, causing breaks in DNA inside cancer cells, preventing them from dividing. Useful for Testicular cancer and Small Cell Lung Cancer (SCLC). Side effects: Vomiting, alopecia, bone marrow suppression.
Camptothecin Analogues (Irinotecan, Topotecan): Inhibit Topoisomerase I.

Influence Amino Acid Supply / Miscellaneous:

L-Asparaginase: Depletes the amino acid asparagine, inhibiting protein synthesis. Used IV for ALL in children. Toxicity: Hepatotoxicity, mental depression, pancreatitis.
Mitotane: Used for Adrenocortical carcinoma. Toxicity: Adrenal insufficiency, lethargy, diarrhea.

5. Hormones, Antagonists, and Related Agents

Influence hormone homeostasis in hormone-sensitive tumors.

Agent	Cancers Where Preferred	Delayed Toxicity / Comments
Corticosteroids (Hydrocortisone, Prednisone)	ALL, CLL, NHL, Hodgkin's, Multiple myeloma	Fluid retention, hypertension, diabetes mellitus, susceptibility to infection, moon face.
Androgens (Testosterone)	Premenopausal breast cancer (estrogen receptor positive)	Fluid retention, masculinization.
Oestrogens (Diethylstilboestrol, Ethinyloestradiol)	Carcinoma prostate, Postmenopausal breast cancer (ER negative)	Feminization in males, fluid retention.
Progestins (Hydroxyprogesterone, Medroxyprogesterone)	Carcinoma endometrium	None significant.
Antiandrogens (Flutamide, Bicalutamide)	Carcinoma prostate	None significant.
Antiestrogens (Tamoxifen - SERM)	Carcinoma breast (early stage, metastatic after surgery)	Risk of endometrial proliferation/cancer.
GnRH Agonists (Goserelin, Leuprolide)	Carcinoma prostate	Medical castration effect.
Aromatase Inhibitors (Letrozole, Anastrozole, Aminoglutethimide)	Metastatic breast cancer (postmenopausal)	Osteoporosis.
Peptide Hormone Inhibitors (Octreotide)	Carcinoid tumour	Controls severe carcinoid syndrome symptoms.

6. Targeted Therapies: Tyrosine Kinase Inhibitors (TKIs) & Monoclonal Antibodies

Tyrosine Kinase Inhibitors (Target specific intracellular signaling pathways):

Drug	Inhibits TK activated by:	Indication
Axitinib / Pazopanib	VEGFR - 1,2,3 / abl-bcr	Advanced renal cell carcinoma
Imatinib	Abl-bcr (Philadelphia chromosome), c-KIT	CML, GIST (Gastrointestinal Stromal Tumor)
Bosutinib / Dasatinib / Nilotinib	Abl-bcr, src, VEGFR	CML (often for Imatinib-resistant cases)
Crizotinib	c-MET, ALK	Non-small cell lung carcinoma (ALK-positive)
Cabozantinib / Vandetanib	c-MET, VEGFR-2, EGFR	Medullary carcinoma thyroid
Erlotinib / Gefitinib	EGFR, abl-bcr, PDGF	Non-small cell lung carcinoma, Pancreatic carcinoma
Lapatinib	HER-2/neu, erb-B2, abl-bcr	Breast carcinoma (HER2 positive)
Regorafenib	VDGFR2, TIE2	Colorectal carcinoma, GIST
Ruxolitinib / Tofacitinib	JAK 1,2	Myelofibrosis / Rheumatoid arthritis
Sorafenib / Sunitinib	VEGFR, PDGFR, RAF, c-KIT, RET	Renal cell carcinoma, Hepatocellular carcinoma, Pancreatic neuroendocrine, GIST
Vemurafenib	BRAF	Malignant melanoma (BRAF V600E positive)

Monoclonal Antibodies (Target specific extracellular antigens):

Monoclonal Antibody	Targeted Against	Indication	Comments / Toxicities
Rituximab	CD-20	Non-Hodgkin lymphoma, CLL	Infusion reactions common.
Alemtuzumab	CD-52	Low grade lymphomas and CLL	Profound immunosuppression.
Trastuzumab	HER 2/neu	Breast Carcinoma (metastatic)	Can cause severe cardiotoxicity / cardiac failure.
Cetuximab / Panitumumab	EGFR	EGFR-positive metastatic colorectal carcinoma	Causes rash, Hypomagnesemia, and Interstitial lung disease.
Bevacizumab	VEGF (Vascular Endothelial Growth Factor)	Metastatic colorectal carcinoma	Combined with 5-FU. Inhibits angiogenesis.
Gemtuzumab	CD-33	CD-33 Positive AML	Linked to calicheamicin (antibody-drug conjugate).
Tositumomab (I-131) / Ibritumomab (Y-90)	CD-20	Relapsed lymphomas	Conjugated with radioisotopes for targeted radiation.
Denileukin diftitox	IL-2 receptor	Recurrent cutaneous T-cell lymphoma	Recombinant IL-2 plus diphtheria toxin.

V. Therapy of Choice for Various Cancers

Modern oncology relies heavily on standardized, combination protocols based on extensive clinical trials.

Diagnosis	Treatment of Choice (Regimen)
Acute Lymphocytic Leukaemia (ALL)	Induction: Vincristine + Prednisolone + Daunorubicin + Asparaginase + Intrathecal Methotrexate. Maintenance: Methotrexate + 6-Mercaptopurine + Cyclophosphamide. Consolidation: Hyper-CVAD alternated with Cytarabine+Methotrexate.
Acute Myeloid Leukaemia (AML)	Cytarabine + Daunorubicin/Idarubicin.
Chronic Myelogenous Leukaemia (CML)	Imatinib (Busulfan or Interferon as alternatives). Bone marrow transplant in selected patients.
Chronic Lymphocytic Leukaemia (CLL)	FCR (Fludarabine, Cyclophosphamide, Rituximab) or Fludarabine/Chlorambucil+Prednisone alone.
Hairy cell leukemia	Cladribine.
Hodgkin's disease	Stage I/II: Radiotherapy. Stage III/IV: ABVD (Doxorubicin [Adriamycin], Bleomycin, Vinblastine, Dacarbazine).
Non-Hodgkin lymphoma	CHOP-R (Cyclophosphamide, Doxorubicin, Vincristine, Prednisolone + Rituximab).
Multiple Myeloma	Bortezomib + Dexamethasone + Lenalidomide (or Melphalan + Prednisone).
Waldenstrom macroglobulinemia	FCR (Fludarabine, Cyclophosphamide, Rituximab).
Polycythemia vera	Hydroxyurea (or Busulfan/Chlorambucil).
Choriocarcinoma	Methotrexate + folic acid OR Cisplatin + Etoposide.
Carcinoma testis	Bleomycin + Cisplatin + Etoposide (BEP regimen).
Wilm's tumour	Surgery + radiotherapy followed by Vincristine + Dactinomycin.
Non-small cell lung cancer	Cisplatin + Vinorelbine ± Bevacizumab.
Small cell lung cancer	Cisplatin + Etoposide.
Mesothelioma	Cisplatin + Pemetrexed.
Head and neck cancer	Cisplatin + 5-FU.
Carcinoma breast stage 1	Tamoxifen after breast surgery.
Carcinoma breast stage II to IV	Cyclophosphamide + Methotrexate + 5-FU (CMF) OR Trastuzumab + Prednisone + Antiestrogen.
Carcinoma ovary	Cisplatin/Carboplatin + Paclitaxel + Interferon.
Carcinoma prostate	GnRH agonist OR Oestrogen + Androgen antagonist (Flutamide).
Melanoma	Dacarbazine, Cisplatin, Interferon.
Carcinoma adrenal gland	Mitotane.
Carcinoid tumour	Doxorubicin + Cyclophosphamide OR 5-FU + Octreotide.

NURSING CARE PLAN & CONSIDERATIONS FOR CHEMOTHERAPY

I. Nursing Assessment & Monitoring

Contraindications Check: Assess for drug allergies, severe hepatorenal impairment, pre-existing bone marrow suppression, and verify pregnancy/lactation status (ensure barrier contraception is utilized by women of childbearing age).
Baseline Physical Assessment: Check orientation, reflexes, vital signs, bowel sounds, and oral mucosa to establish baseline data before therapy begins.
Laboratory Monitoring:
- CBC with differential: Crucial to identify bone marrow suppression (leukopenia, neutropenia, thrombocytopenia, anemia). Calculates the Absolute Neutrophil Count (ANC).
- Renal/Hepatic panels (BUN, Creatinine, AST, ALT, Bilirubin): To determine the need for dose adjustments and identify toxicities.
- Uric Acid: Monitor for Tumor Lysis Syndrome (prophylactic Allopurinol or Rasburicase may be needed).

II. Nursing Care Plan

No.	Nursing Diagnosis	Interventions & Rationale
1	Risk for Infection related to chemotherapy-induced leukopenia and immunosuppression.	Institute strict neutropenic precautions: Hand hygiene, avoid fresh flowers/plants, and raw unpeeled fruits/vegetables to prevent exposure to environmental pathogens. Monitor temperature daily: A fever >38°C (100.4°F) in a neutropenic patient is a medical emergency requiring immediate broad-spectrum antibiotics. Administer Colony-Stimulating Factors (e.g., Filgrastim/Peg-filgrastim) as ordered: Stimulates the bone marrow to accelerate neutrophil recovery.
2	Imbalanced Nutrition: Less than body requirements related to severe nausea, vomiting (CTZ stimulation), and stomatitis/mucositis.	Administer antiemetics prophylactically: Give agents like Ondansetron (5-HT3 antagonists) 30-60 minutes before chemotherapy administration. For delayed emesis (like with Cisplatin), administer Aprepitant. Provide frequent, small, high-calorie, bland meals: Easier to digest and less likely to trigger nausea than large, spicy, or hot meals. Implement meticulous oral hygiene: Use soft-bristled toothbrushes and non-alcoholic mouthwashes (or administer Palifermin) to soothe stomatitis and prevent bleeding gums or candidiasis.
3	Risk for Bleeding related to chemotherapy-induced thrombocytopenia.	Implement bleeding precautions: Avoid IM injections, use electric razors, and prevent hard nose-blowing to avoid inducing uncontrollable hemorrhage. Monitor for petechiae, ecchymosis, or melena: Early clinical indicators of dangerously low platelet counts. Administer Platelet/Granulocyte transfusions or Oprelvekin (IL-11): As indicated to manage severe thrombocytopenia.
4	Disturbed Body Image related to alopecia and physical changes from targeted therapies (e.g., severe acneiform rash).	Educate prior to hair loss: Inform the patient that hair loss is usually temporary and will regrow after therapy cessation. Suggest exploring wigs, hats, or scarves beforehand. Provide emotional support: Validate their feelings regarding their changing appearance; refer to oncological support groups if appropriate.
5	Risk for Impaired Tissue Integrity (Vesicant Toxicity) related to extravasation of alkylating agents or antibiotics (e.g., Mechlorethamine, Doxorubicin, Vincristine).	Ensure patent IV access via central line or port: Peripheral lines are highly risky for vesicants. Check for blood return prior to administration. Monitor IV site continuously during infusion: If swelling, pain, or redness occurs, stop the infusion immediately, aspirate residual drug, and follow hospital extravasation protocols.

References

Presentation Slides: Treatment options of cancer / Anticancer drugs (Slides 57 pages detailing Cell Cycle, Alkylating Agents, Antimetabolites, Antibiotics, Targeted Therapies, Toxicities, and Therapy of Choice).
Brunton, L. L., Hilal-Dandan, R., & Knollmann, B. C. (2017). Goodman & Gilman's The Pharmacological Basis of Therapeutics (13th ed.). McGraw-Hill Education.
Katzung, B. G. (2017). Basic & Clinical Pharmacology (14th ed.). McGraw-Hill Education.
Nursing considerations adapted from Oncology Nursing Society (ONS) guidelines for safe handling and administration of chemotherapy.

Quick Quiz

Anticancer Drugs Quiz

Pharmacology - mobile-friendly and focused practice.

Full Name Email Address

Privacy: Your details are used only for quiz tracking and certificates.

Antineoplastic Agents Read More »

nursesrevision@gmail.com

FIRST AID KIT

Components of a First Aid Kit

PERSONAL PROTECTION OF A FIRST AIDER DURING FIRST AID.

EMERGENCY

ASSESSING A CASUALTY.

POSITIONING OF A CASUALTY:

RESUSCITATION (BASIC LIFE SUPPORT)

THE RESUSCITATION SEQUENCE

First Aid

AIMS OF FIRST AID

SCOPE OF FIRST AID

PRIORITIES OF TREATMENT IN CASE OF AN ACCIDENT

QUALITIES OF A GOOD FIRST AIDER

OBJECTIVES OF FIRST AID

BASIC OBJECTIVES OF PSYCHOLOGICAL FIRST AID

GOLDEN RULES OF FIRST AID

PRINCIPLES OF FIRST AID (ACTION AT AN EMERGENCY)

GENERAL RULES OF FIRST AID

DO’S AND DON’T’S

STEP BY STEP ACTION TO BE TAKEN BY THE FIRST AIDER

RESPONSIBILITIES OF A FIRST AIDER IN THE MANAGEMENT OF CASUALTIES:

LIMITATIONS OF THE FIRST AIDER

SKILLS REQUIRED FOR THE FIRST AIDER:

Guide to the Question Approach for Midwifery Exams

Explaining Questions: Breaking Down Complex Concepts

Outlining Questions: Structuring Information

Describing Questions: Providing Detailed Information

Mentioning, Identifying, and Stating Questions: Being Clear and Concise

Listing and Giving Questions: Providing Comprehensive Information

Write Short Notes: Concise and Informative Summaries

What Questions: Providing Clear Definitions and Explanations

Tips for Success:

HYPERTENSION

Introduction

Types of Hypertension

Stages of Hypertension

Proper Measurement of Blood Pressure

Pathophysiology

Causes of Hypertension

Risk factors of Hypertension

Clinical manifestations

Test and Diagnosis for Hypertension

Management

Medical Management

Drug therapy

Lifestyle modification

Nursing management

1. Assessment of the patient

2. To prevent the heart failure as a result of BP > 140 systolic

3. To relieve pain (head ache among others)

4. Diet

5. To promote patient’s knowledge:

6. Discharge and Home Care Guidelines

Complications of Hypertension

Drug Therapy for Hypertension

Choice of Antihypertensive

Choice of Antihypertensive in Different Conditions

Resistant Hypertension

Causes:

Malignant Hypertension, Hypertensive Emergency, Hypertensive Urgency

Malignant Hypertension

Clinical Presentation:

Hypertensive Emergency

Hypertensive Urgency

Drugs Used in the Treatment of Hypertension

1. Beta Blockers

Examples:

Mechanism of Action:

Indications:

Side Effects:

Contraindications:

2. Calcium Channel Blockers

Examples:

Mechanism of Action:

Indications:

Side Effects:

Contraindications:

3. Diuretics

Classification of Diuretics: